0001987731FALSE12/312026Q2P1MP3Moneonexbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:purewti:class_of_financial_instrumentwti:loanwti:segment00019877312026-01-012026-06-3000019877312026-08-1300019877312026-06-3000019877312025-12-310001987731wti:CumulativeReturnOfCapitalDistributionsMember2026-06-300001987731wti:CumulativeReturnOfCapitalDistributionsMember2025-12-310001987731wti:DistributableIncomeLossMember2026-06-300001987731wti:DistributableIncomeLossMember2025-12-3100019877312026-04-012026-06-3000019877312025-04-012025-06-3000019877312025-01-012025-06-300001987731us-gaap:CommonStockMember2025-03-310001987731us-gaap:AdditionalPaidInCapitalMember2025-03-310001987731wti:CumulativeReturnOfCapitalDistributionsMember2025-03-310001987731wti:DistributableIncomeLossMember2025-03-3100019877312025-03-310001987731wti:DistributableIncomeLossMember2025-04-012025-06-300001987731wti:CumulativeReturnOfCapitalDistributionsMember2025-04-012025-06-300001987731us-gaap:CommonStockMember2025-06-300001987731us-gaap:AdditionalPaidInCapitalMember2025-06-300001987731wti:CumulativeReturnOfCapitalDistributionsMember2025-06-300001987731wti:DistributableIncomeLossMember2025-06-3000019877312025-06-300001987731us-gaap:CommonStockMember2026-03-310001987731us-gaap:AdditionalPaidInCapitalMember2026-03-310001987731wti:CumulativeReturnOfCapitalDistributionsMember2026-03-310001987731wti:DistributableIncomeLossMember2026-03-3100019877312026-03-310001987731wti:DistributableIncomeLossMember2026-04-012026-06-300001987731wti:CumulativeReturnOfCapitalDistributionsMember2026-04-012026-06-300001987731us-gaap:AdditionalPaidInCapitalMember2026-04-012026-06-300001987731us-gaap:CommonStockMember2026-06-300001987731us-gaap:AdditionalPaidInCapitalMember2026-06-300001987731wti:CumulativeReturnOfCapitalDistributionsMember2026-06-300001987731wti:DistributableIncomeLossMember2026-06-300001987731us-gaap:CommonStockMember2024-12-310001987731us-gaap:AdditionalPaidInCapitalMember2024-12-310001987731wti:CumulativeReturnOfCapitalDistributionsMember2024-12-310001987731wti:DistributableIncomeLossMember2024-12-3100019877312024-12-310001987731wti:DistributableIncomeLossMember2025-01-012025-06-300001987731wti:CumulativeReturnOfCapitalDistributionsMember2025-01-012025-06-300001987731us-gaap:AdditionalPaidInCapitalMember2025-01-012025-06-300001987731us-gaap:CommonStockMember2025-12-310001987731us-gaap:AdditionalPaidInCapitalMember2025-12-310001987731wti:CumulativeReturnOfCapitalDistributionsMember2025-12-310001987731wti:DistributableIncomeLossMember2025-12-310001987731wti:DistributableIncomeLossMember2026-01-012026-06-300001987731wti:CumulativeReturnOfCapitalDistributionsMember2026-01-012026-06-300001987731us-gaap:AdditionalPaidInCapitalMember2026-01-012026-06-300001987731Biolojic Design Ltd. | Senior Secured 2026-06-300001987731Teiko Bio, Inc. | Senior Secured 12026-06-300001987731Teiko Bio, Inc. | Senior Secured 22026-06-300001987731wti:TeikoBioInc.Memberwti:LoanInvestmentsBiotechnologyMember2026-06-300001987731wti:LoanInvestmentsBiotechnologyMember2026-06-300001987731Proto, Inc. | Senior Secured2026-06-300001987731wti:LoanInvestmentsComputersAndStorageMember2026-06-300001987731BossBites Inc. | Senior Secured2026-06-300001987731Realm Living, Inc. | Senior Secured2026-06-300001987731Slice Solutions, Inc.| Senior Secured2026-06-300001987731wti:LoanInvestmentsInternetMember2026-06-300001987731eXo Imaging, Inc. | Senior Secured2026-06-300001987731Gallant Pet, Inc. | Senior Secured 12026-06-300001987731Gallant Pet, Inc. | Senior Secured 22026-06-300001987731wti:GallantPetInc.Memberwti:LoanInvestmentsMedicalDevicesMember2026-06-300001987731wti:LoanInvestmentsMedicalDevicesMember2026-06-300001987731Lark Technologies, Inc. | Senior Secured2026-06-300001987731MeMed Diagnostics Ltd. | Senior Secured 12026-06-300001987731MeMed Diagnostics Ltd. | Senior Secured 22026-06-300001987731MeMed Diagnostics Ltd. | Senior Secured 32026-06-300001987731wti:MeMedDiagnosticsLtd.Memberwti:LoanInvestmentsOtherHealthcareMember2026-06-300001987731Vitable, Inc. | Senior Secured 12026-06-300001987731Vitable, Inc. | Senior Secured 22026-06-300001987731wti:VitableInc.Memberwti:LoanInvestmentsOtherHealthcareMember2026-06-300001987731wti:LoanInvestmentsOtherHealthcareMember2026-06-300001987731AI Tech Holdings, Inc. | Senior Secured2026-06-300001987731Allocate Holdings Inc. | Senior Secured2026-06-300001987731Belong, Inc. | Senior Secured 12026-06-300001987731Belong, Inc. | Senior Secured 22026-06-300001987731Belong, Inc. | Senior Secured 32026-06-300001987731wti:BelongInc.Memberwti:LoanInvestmentsOtherTechnologyMember2026-06-300001987731Brick Dynamics Inc. | Senior Secured 12026-06-300001987731Brick Dynamics Inc. | Senior Secured 22026-06-300001987731wti:BrickDynamicsInc.Memberwti:LoanInvestmentsOtherTechnologyMember2026-06-300001987731Carbon Ridge, Inc. | Senior Secured 12026-06-300001987731Carbon Ridge, Inc. | Senior Secured 22026-06-300001987731wti:CarbonRidgeInc.Memberwti:LoanInvestmentsOtherTechnologyMember2026-06-300001987731Cofertility, Inc. | Senior Secured2026-06-300001987731Creoate Limited | Senior Secured 12026-06-300001987731Creoate Limited | Senior Secured 22026-06-300001987731Creoate Limited | Senior Secured 32026-06-300001987731Creoate Limited | Senior Secured 42026-06-300001987731Creoate Limited | Senior Secured 52026-06-300001987731Creoate Limited | Senior Secured 62026-06-300001987731Creoate Limited | Senior Secured 72026-06-300001987731Creoate Limited | Senior Secured 82026-06-300001987731Creoate Limited | Senior Secured 92026-06-300001987731Creoate Limited | Senior Secured 102026-06-300001987731Creoate Limited | Senior Secured 112026-06-300001987731wti:CreoateLimitedMemberwti:LoanInvestmentsOtherTechnologyMember2026-06-300001987731Daisyco, Inc. | Senior Secured2026-06-300001987731Fortull, Inc. | Senior Secured 12026-06-300001987731Fortull, Inc. | Senior Secured 22026-06-300001987731wti:FortullInc.Memberwti:LoanInvestmentsOtherTechnologyMember2026-06-300001987731Gold Words, LLC | Senior Secured2026-06-300001987731Grin Technology Services Inc. | Senior Secured2026-06-300001987731Hint, Inc. | Senior Secured2026-06-300001987731Innventure LLC | Senior Secured2026-06-300001987731Joy Memories, Inc | Senior Secured2026-06-300001987731Kindred Motorworks, Inc. | Senior Secured2026-06-300001987731Scripta Insights, Inc. | Senior Secured2026-06-300001987731Umbra Lab, Inc. | Senior Secured 12026-06-300001987731Umbra Lab, Inc. | Senior Secured 22026-06-300001987731wti:UmbraLabInc.Memberwti:LoanInvestmentsOtherTechnologyMember2026-06-300001987731wti:LoanInvestmentsOtherTechnologyMember2026-06-300001987731D2S, Inc. | Senior Secured2026-06-300001987731wti:LoanInvestmentsSemiconductorsAndEquipmentMember2026-06-300001987731APIsecAI, Inc. | Senior Secured 12026-06-300001987731APIsecAI, Inc. | Senior Secured 22026-06-300001987731wti:APIsecAIInc.Memberwti:LoanInvestmentsSoftwareMember2026-06-300001987731Bito Inc. | Senior Secured2026-06-300001987731Canvas Medical, Inc. | Senior Secured2026-06-300001987731Checksum AI, Inc. | Senior Secured2026-06-300001987731Crowded Technologies, Inc. | Senior Secured 12026-06-300001987731Crowded Technologies, Inc. | Senior Secured 22026-06-300001987731wti:CrowdedTechnologiesInc.Memberwti:LoanInvestmentsSoftwareMember2026-06-300001987731Evolver Transformation, Inc. | Senior Secured2026-06-300001987731Global Publishing Interactive, Inc. | Senior Secured2026-06-300001987731Jericho Secuity, Inc. | Senior Secured2026-06-300001987731Merlyn Mind, Inc. | Senior Secured 12026-06-300001987731Merlyn Mind, Inc. | Senior Secured 22026-06-300001987731Merlyn Mind, Inc. | Senior Secured 32026-06-300001987731wti:MerlynMindInc.Memberwti:LoanInvestmentsSoftwareMember2026-06-300001987731Outbuild Technologies, Inc. | Senior Secured2026-06-300001987731Safe Securities Inc. | Senior Secured2026-06-300001987731Truepic Inc. | Senior Secured 12026-06-300001987731Truepic Inc. | Senior Secured 22026-06-300001987731wti:TruepicInc.Memberwti:LoanInvestmentsSoftwareMember2026-06-300001987731Vesta Housing, Inc. | Senior Secured2026-06-300001987731Workspot, Inc. | Senior Secured2026-06-300001987731ZeroCater, Inc. | Senior Secured2026-06-300001987731wti:LoanInvestmentsSoftwareMember2026-06-300001987731Ava Finance, Inc. | Senior Secured 12026-06-300001987731Ava Finance, Inc. | Senior Secured 22026-06-300001987731Ava Finance, Inc. | Senior Secured 32026-06-300001987731Ava Finance, Inc. | Senior Secured 42026-06-300001987731Ava Finance, Inc. | Senior Secured 52026-06-300001987731Ava Finance, Inc. | Senior Secured 62026-06-300001987731Ava Finance, Inc. | Senior Secured 72026-06-300001987731wti:AvaFinanceInc.Memberwti:LoanInvestmentsTechnologyServicesMember2026-06-300001987731Klar Holdings Limited | Senior Secured 12026-06-300001987731Klar Holdings Limited | Senior Secured 22026-06-300001987731Klar Holdings Limited | Senior Secured 32026-06-300001987731wti:KlarHoldingsLimitedMemberwti:LoanInvestmentsTechnologyServicesMember2026-06-300001987731Prima Holdings Limited | Senior Secured2026-06-300001987731wti:LoanInvestmentsTechnologyServicesMember2026-06-300001987731Juvo Mobile, Inc. | Senior Secured2026-06-300001987731wti:LoanInvestmentsWirelessMember2026-06-300001987731Biolojic Design Ltd. | Senior Secured 12025-12-310001987731Biolojic Design Ltd. | Senior Secured 22025-12-310001987731wti:BiolojicDesignLtd.Memberwti:LoanInvestmentsBiotechnologyMember2025-12-310001987731wti:LoanInvestmentsBiotechnologyMember2025-12-310001987731Proto, Inc. | Senior Secured2025-12-310001987731wti:LoanInvestmentsComputersAndStorageMember2025-12-310001987731Realm Living, Inc. | Senior Secured2025-12-310001987731wti:LoanInvestmentsInternetMember2025-12-310001987731eXo Imaging, Inc. | Senior Secured2025-12-310001987731Gallant Pet, Inc. | Senior Secured 12025-12-310001987731Gallant Pet, Inc. | Senior Secured 22025-12-310001987731wti:GallantPetInc.Memberwti:LoanInvestmentsMedicalDevicesMember2025-12-310001987731wti:LoanInvestmentsMedicalDevicesMember2025-12-310001987731Lark Technologies, Inc. | Senior Secured2025-12-310001987731Vitable, Inc. | Senior Secured2025-12-310001987731wti:LoanInvestmentsOtherHealthcareMember2025-12-310001987731AI Tech Holdings, Inc. | Senior Secured2025-12-310001987731Belong, Inc. | Senior Secured 12025-12-310001987731Belong, Inc. | Senior Secured 22025-12-310001987731wti:BelongInc.Memberwti:LoanInvestmentsOtherTechnologyMember2025-12-310001987731Carbon Ridge, Inc. | Senior Secured 12025-12-310001987731Carbon Ridge, Inc. | Senior Secured 22025-12-310001987731wti:CarbonRidgeInc.Memberwti:LoanInvestmentsOtherTechnologyMember2025-12-310001987731Creoate Limited | Senior Secured 12025-12-310001987731Creoate Limited | Senior Secured 22025-12-310001987731Creoate Limited | Senior Secured 32025-12-310001987731Creoate Limited | Senior Secured 42025-12-310001987731Creoate Limited | Senior Secured 52025-12-310001987731Creoate Limited | Senior Secured 62025-12-310001987731Creoate Limited | Senior Secured 72025-12-310001987731Creoate Limited | Senior Secured 82025-12-310001987731Creoate Limited | Senior Secured 92025-12-310001987731Creoate Limited | Senior Secured 102025-12-310001987731wti:CreoateLimitedMemberwti:LoanInvestmentsOtherTechnologyMember2025-12-310001987731Daisyco, Inc. | Senior Secured2025-12-310001987731Fortull, Inc. | Senior Secured2025-12-310001987731Gold Words, LLC | Senior Secured2025-12-310001987731Hint, Inc. | Senior Secured2025-12-310001987731Innventure LLC | Senior Secured2025-12-310001987731Kindred Motorworks, Inc. | Senior Secured2025-12-310001987731Last Energy Inc. | Senior Secured2025-12-310001987731Owlet Baby Care, Inc. | Senior Secured2025-12-310001987731Scripta Insights, Inc. | Senior Secured2025-12-310001987731Umbra Lab, Inc. | Senior Secured2025-12-310001987731wti:LoanInvestmentsOtherTechnologyMember2025-12-310001987731APIsecAI, Inc. | Senior Secured 12025-12-310001987731APIsecAI, Inc. | Senior Secured 22025-12-310001987731wti:APIsecAIInc.Memberwti:LoanInvestmentsSoftwareMember2025-12-310001987731Bito Inc. | Senior Secured2025-12-310001987731Confirm HR, Inc. | Senior Secured2025-12-310001987731Crowded Technologies, Inc. | Senior Secured 12025-12-310001987731Crowded Technologies, Inc. | Senior Secured 22025-12-310001987731wti:CrowdedTechnologiesInc.Memberwti:LoanInvestmentsSoftwareMember2025-12-310001987731Manifold Inc. | Senior Secured 12025-12-310001987731Manifold Inc. | Senior Secured 22025-12-310001987731wti:ManifoldInc.Memberwti:LoanInvestmentsSoftwareMember2025-12-310001987731Merlyn Mind, Inc. | Senior Secured2025-12-310001987731Safe Securities Inc. | Senior Secured2025-12-310001987731Standard Dental OpCo, Inc. | Senior Secured 12025-12-310001987731Standard Dental OpCo, Inc. | Senior Secured 22025-12-310001987731wti:StandardDentalOpCoInc.Memberwti:LoanInvestmentsSoftwareMember2025-12-310001987731Truepic Inc. | Senior Secured 12025-12-310001987731Truepic Inc. | Senior Secured 22025-12-310001987731wti:TruepicInc.Memberwti:LoanInvestmentsSoftwareMember2025-12-310001987731Vesta Housing, Inc. | Senior Secured 12025-12-310001987731Vesta Housing, Inc. | Senior Secured 22025-12-310001987731Vesta Housing, Inc. | Senior Secured 32025-12-310001987731wti:VestaHousingInc.Memberwti:LoanInvestmentsSoftwareMember2025-12-310001987731ZeroCater, Inc. | Senior Secured2025-12-310001987731wti:LoanInvestmentsSoftwareMember2025-12-310001987731Ava Finance, Inc. | Senior Secured 12025-12-310001987731Ava Finance, Inc. | Senior Secured 22025-12-310001987731Ava Finance, Inc. | Senior Secured 32025-12-310001987731Ava Finance, Inc. | Senior Secured 42025-12-310001987731Ava Finance, Inc. | Senior Secured 52025-12-310001987731Ava Finance, Inc. | Senior Secured 62025-12-310001987731Ava Finance, Inc. | Senior Secured 72025-12-310001987731wti:AvaFinanceInc.Memberwti:LoanInvestmentsTechnologyServicesMember2025-12-310001987731Klar Holdings Limited | Senior Secured 12025-12-310001987731Klar Holdings Limited | Senior Secured 22025-12-310001987731Klar Holdings Limited | Senior Secured 32025-12-310001987731wti:KlarHoldingsLimitedMemberwti:LoanInvestmentsTechnologyServicesMember2025-12-310001987731Prima Holdings Limited | Senior Secured2025-12-310001987731wti:LoanInvestmentsTechnologyServicesMember2025-12-310001987731Juvo Mobile, Inc. | Senior Secured2025-12-310001987731wti:LoanInvestmentsWirelessMember2025-12-310001987731wti:WTIFundXIInc.Memberwti:WTIFundXILLCMember2026-01-012026-06-300001987731wti:WTIFundXILLCMember2023-02-012023-02-010001987731wti:WTIFundXILLCMember2023-02-010001987731wti:PerformingLoansMembersrt:WeightedAverageMember2026-04-012026-06-300001987731wti:PerformingLoansMembersrt:WeightedAverageMember2025-04-012025-06-300001987731wti:PerformingLoansMembersrt:WeightedAverageMember2026-01-012026-06-300001987731wti:PerformingLoansMembersrt:WeightedAverageMember2025-01-012025-06-300001987731srt:WeightedAverageMember2026-04-012026-06-300001987731srt:WeightedAverageMember2025-04-012025-06-300001987731srt:WeightedAverageMember2026-01-012026-06-300001987731srt:WeightedAverageMember2025-01-012025-06-300001987731wti:LoanInvestmentsBiotechnologyMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsBiotechnologyMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsBiotechnologyMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsBiotechnologyMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsComputersAndStorageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsComputersAndStorageMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsComputersAndStorageMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsInternetMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsInternetMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsInternetMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsInternetMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsMedicalDevicesMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsMedicalDevicesMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsMedicalDevicesMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsMedicalDevicesMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsOtherHealthcareMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsOtherHealthcareMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsOtherHealthcareMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsOtherHealthcareMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsOtherTechnologyMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsOtherTechnologyMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsOtherTechnologyMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsOtherTechnologyMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsSemiconductorsAndEquipmentMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsSemiconductorsAndEquipmentMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsSemiconductorsAndEquipmentMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsSoftwareMemberus-gaap:FairValueInputsLevel3Memberwti:MostAdvantageousMarketAnalysisAndAssetRecoveryMember2026-06-300001987731wti:LoanInvestmentsSoftwareMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsSoftwareMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsSoftwareMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsSoftwareMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2026-06-300001987731wti:LoanInvestmentsSoftwareMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2026-06-300001987731wti:LoanInvestmentsTechnologyServicesMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsTechnologyServicesMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsTechnologyServicesMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsTechnologyServicesMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsWirelessMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsWirelessMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731wti:LoanInvestmentsWirelessMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001987731us-gaap:FairValueInputsLevel3Member2026-06-300001987731wti:LoanInvestmentsBiotechnologyMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsBiotechnologyMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsBiotechnologyMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsComputersAndStorageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsComputersAndStorageMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsComputersAndStorageMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsInternetMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsInternetMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsInternetMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsMedicalDevicesMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsMedicalDevicesMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsMedicalDevicesMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsMedicalDevicesMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsOtherHealthcareMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsOtherHealthcareMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsOtherHealthcareMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsOtherTechnologyMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsOtherTechnologyMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsOtherTechnologyMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsOtherTechnologyMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsSoftwareMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsSoftwareMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsSoftwareMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsSoftwareMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsTechnologyServicesMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsTechnologyServicesMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsTechnologyServicesMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsTechnologyServicesMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsWirelessMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsWirelessMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731wti:LoanInvestmentsWirelessMemberwti:MeasurementInputMostAdvantageousMarketEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001987731us-gaap:FairValueInputsLevel3Member2025-12-3100019877312025-01-012025-12-310001987731us-gaap:FairValueInputsLevel1Member2026-06-300001987731us-gaap:FairValueInputsLevel2Member2026-06-300001987731us-gaap:FairValueInputsLevel1Member2025-12-310001987731us-gaap:FairValueInputsLevel2Member2025-12-310001987731us-gaap:LoansMember2026-03-310001987731us-gaap:WarrantMember2026-03-310001987731us-gaap:LoansMember2025-12-310001987731us-gaap:WarrantMember2025-12-310001987731us-gaap:LoansMember2026-04-012026-06-300001987731us-gaap:WarrantMember2026-04-012026-06-300001987731us-gaap:LoansMember2026-01-012026-06-300001987731us-gaap:WarrantMember2026-01-012026-06-300001987731us-gaap:LoansMember2026-06-300001987731us-gaap:WarrantMember2026-06-300001987731us-gaap:LoansMember2025-03-310001987731us-gaap:WarrantMember2025-03-310001987731us-gaap:LoansMember2024-12-310001987731us-gaap:WarrantMember2024-12-310001987731us-gaap:LoansMember2025-04-012025-06-300001987731us-gaap:WarrantMember2025-04-012025-06-300001987731us-gaap:LoansMember2025-01-012025-06-300001987731us-gaap:WarrantMember2025-01-012025-06-300001987731us-gaap:LoansMember2025-06-300001987731us-gaap:WarrantMember2025-06-300001987731wti:WTIFundXILLCMember2026-06-300001987731wti:WTIFundXILLCMember2025-12-310001987731wti:CashDividendDistributionMember2026-01-012026-06-300001987731wti:CashDividendDistributionMember2025-01-012025-06-300001987731wti:EquityDividendDistributionMember2026-01-012026-06-300001987731wti:EquityDividendDistributionMember2025-01-012025-06-300001987731us-gaap:RevolvingCreditFacilityMemberwti:LoanAgreementMember2024-08-010001987731us-gaap:LineOfCreditMemberwti:LoanAgreementMemberwti:VariableRateComponentOneMemberus-gaap:RevolvingCreditFacilityMember2026-01-012026-06-300001987731us-gaap:LineOfCreditMemberwti:LoanAgreementMemberwti:VariableRateComponentTwoMemberus-gaap:RevolvingCreditFacilityMember2026-01-012026-06-300001987731us-gaap:LineOfCreditMemberwti:LoanAgreementMemberwti:VariableRateComponentThreeMemberus-gaap:RevolvingCreditFacilityMember2026-01-012026-06-300001987731us-gaap:LineOfCreditMemberwti:LoanAgreementMemberus-gaap:RevolvingCreditFacilityMember2026-06-300001987731us-gaap:LineOfCreditMemberwti:LoanAgreementMemberus-gaap:RevolvingCreditFacilityMember2026-01-012026-06-300001987731us-gaap:LineOfCreditMemberwti:LoanAgreementMembersrt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2026-01-012026-06-300001987731us-gaap:LineOfCreditMemberwti:LoanAgreementMembersrt:MaximumMemberus-gaap:RevolvingCreditFacilityMember2026-01-012026-06-300001987731us-gaap:LineOfCreditMemberwti:LoanAgreementMemberus-gaap:RevolvingCreditFacilityMember2025-12-310001987731wti:ManagementFeePeriodOneMember2026-01-012026-06-300001987731wti:ManagementFeePeriodTwoMember2026-01-012026-06-300001987731wti:ManagementFeePeriodThreeMember2026-01-012026-06-300001987731wti:ManagementFeePeriodFourMember2026-01-012026-06-300001987731wti:ManagementFeePeriodFiveMember2026-01-012026-06-300001987731wti:ManagementFeePeriodSixMember2026-01-012026-06-300001987731wti:ManagementFeePeriodSevenMember2026-01-012026-06-300001987731wti:ManagementFeePeriodEightMember2026-01-012026-06-300001987731wti:ManagementFeePeriodNineMember2026-01-012026-06-300001987731wti:ManagementFeeAfterPeriodNineMember2026-06-300001987731Abacum Inc. | Software2026-06-300001987731Belong, Inc. | Other Technology2026-06-300001987731Cofertility, Inc. | Other Technology2026-06-300001987731Crowded Technologies, Inc. | Software2026-06-300001987731eXo Imaging, Inc. | Medical Devices2026-06-300001987731Fortull, Inc. | Other Technology2026-06-300001987731Global Publishing Interactive, Inc. | Software2026-06-300001987731Jericho Secuity, Inc. | Software2026-06-300001987731Lucra Inc. | Software2026-06-300001987731Merlyn Mind, Inc. | Software2026-06-300001987731Orion Longevity, Inc. | Other Technology2026-06-300001987731Outbuild Technologies, Inc. | Software2026-06-300001987731Pioneers Educaton, Inc. | Other Technology2026-06-300001987731Safe Securities Inc. | Software2026-06-300001987731Slice Solutions, Inc. | Internet2026-06-300001987731Workspot, Inc. | Software2026-06-300001987731World View Enterprises Inc. | Other Technology2026-06-300001987731Abacum Inc. | Software2025-12-310001987731Ava Finance, Inc. | Technology Services2025-12-310001987731Bito Inc. | Software2025-12-310001987731Creoate Limited | Other Technology2025-12-310001987731Crowded Technologies, Inc. | Software2025-12-310001987731Daisyco, Inc. | Other Technology2025-12-310001987731eXo Imaging, Inc. | Medical Devices2025-12-310001987731Fortull, Inc. | Other Technology2025-12-310001987731Lark Technologies, Inc. | Other Healthcare2025-12-310001987731Prima Holdings Limited | Technology Services2025-12-310001987731Safe Securities Inc. | Software2025-12-310001987731Teiko Bio, Inc. | Biotechnology2025-12-310001987731Vitable, Inc. | Other Healthcare2025-12-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

[X]QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2026

[  ]TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ______________

Commission file number 814-01718

WTI Fund XI, Inc.
(Exact Name of Registrant as specified in its charter)
Maryland92-1737785
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
104 La Mesa Drive, Suite 102, Portola Valley, CA
94028
(Address of principal executive offices)(Zip Code)

(650) 234-4300
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [x]  No [ ]

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes [x]   No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer [ ]Accelerated filer [ ]
Non-accelerated filer [x]
Smaller reporting company [ ]
Emerging growth company [ ]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes [ ] No [x]
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:
ClassOutstanding as of August 13, 2026
Common Stock, $0.001 par value100,000




WTI FUND XI, INC.
INDEX
PART I — FINANCIAL INFORMATION
Item 1.Financial Statements
Condensed Statements of Assets and Liabilities (Unaudited)
As of June 30, 2026 and December 31, 2025
Condensed Statements of Operations (Unaudited)
For the three and six months ended June 30, 2026 and 2025
Condensed Statements of Changes in Net Assets (Unaudited)
For the three and six months ended June 30, 2026 and 2025
Condensed Statements of Cash Flows (Unaudited)
For the six months ended June 30, 2026 and 2025
Condensed Schedules of Investments (Unaudited)
As of June 30, 2026 and December 31, 2025
Notes to Condensed Financial Statements (Unaudited)
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3.Quantitative and Qualitative Disclosures About Market Risk
Item 4.Controls and Procedures
PART II — OTHER INFORMATION
Item 1.Legal Proceedings
Item 1A.Risk Factors
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds
Item 3.Defaults Upon Senior Securities
Item 4.Mine Safety Disclosures
Item 5.Other Information
Item 6.Exhibits
SIGNATURES




PART I - FINANCIAL INFORMATION

Item 1. Financial Statements
WTI FUND XI, INC.

CONDENSED STATEMENTS OF ASSETS AND LIABILITIES (UNAUDITED)
AS OF JUNE 30, 2026 AND DECEMBER 31, 2025

June 30, 2026December 31, 2025
ASSETS
Loans, at estimated fair value
   (amortized cost of $93,230,476 and $48,835,889, respectively)
$93,230,476 $48,835,889 
Cash
12,787,069 6,085,901 
Dividend and interest receivables1,352,627 1,044,410 
Other assets913,364 1,124,372 
Total assets108,283,536 57,090,572 
LIABILITIES
Borrowings under debt facility66,000,000 28,500,000 
Accrued management fees1,553,530 1,610,685 
Accounts payable and other accrued liabilities837,898 586,146 
Total liabilities68,391,428 30,696,831 
NET ASSETS$39,892,108 $26,393,741 
Analysis of Net Assets:
Capital paid in on shares of capital stock$61,425,000 $40,825,000 
Cumulative return of capital distributions(17,556,403)(10,454,770)
Total distributable losses(3,976,489)(3,976,489)
Net assets (equivalent to $398.92 and $263.94 per share based on 100,000 shares of capital stock outstanding - see Note 5 and Note 10)
$39,892,108 $26,393,741 
Commitments & Contingent Liabilities:
Unexpired unfunded commitments (see Note 8)
$36,000,000 $17,500,000 







See notes to condensed financial statements (unaudited).
3



WTI FUND XI, INC.

CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2026 AND 2025

For the Three Months Ended June 30, 2026
For the Three Months Ended June 30, 2025
For the Six Months Ended June 30, 2026 For the Six Months Ended June 30, 2025
INVESTMENT INCOME:
Interest on loans$4,566,628 $2,261,659 $9,050,895 $3,992,697 
Other income26,775 49,142 31,441 139,783 
Total investment income4,593,403 2,310,801 9,082,336 4,132,480 
EXPENSES:
Management fees1,553,530 $1,533,485 $3,089,988 $3,081,428 
Interest expense1,246,258 883,477 2,191,426 1,744,274 
Banking and professional fees91,413 88,518 142,695 156,015 
Other operating expenses33,446 69,493 102,734 111,967 
Total expenses2,924,647 2,574,973 5,526,843 5,093,684 
Net investment income (loss)
1,668,756 (264,172)3,555,493 (961,204)
Net increase (decrease) in net assets resulting from operations
$1,668,756 $(264,172)$3,555,493 $(961,204)
Amounts per common share:
Net increase (decrease) in net assets resulting from operations per share
$16.69 $(2.64)$35.55 $(9.61)
Weighted average shares outstanding100,000 100,000 100,000 100,000 













See notes to condensed financial statements (unaudited).

4


WTI FUND XI, INC.

CONDENSED STATEMENTS OF CHANGES IN NET ASSETS (UNAUDITED)
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2026 AND 2025
Common Stock
SharesPar ValueAdditional Paid-in CapitalReturn of Capital DistributionsTotal Distributable LossesNet Assets
Balance at March 31, 2025100,000 $100 $32,324,900 $(7,743,338)$(4,439,906)$20,141,756 
Net decrease in net assets resulting from operations— — — — (264,172)(264,172)
Return of capital to shareholder— — — (990,826)— (990,826)
Balance at June 30, 2025100,000 $100 $32,324,900 $(8,734,164)$(4,704,078)$18,886,758 
Balance at March 31, 2026100,000 $100 $47,824,900 $(12,883,184)$(3,976,489)$30,965,327 
Net increase in net assets resulting from operations— — — — 1,668,756 1,668,756 
Distributions of income to shareholder— — — — (1,668,756)(1,668,756)
Return of capital to shareholder— — — (4,673,219)— (4,673,219)
Contributions from shareholder— — 13,600,000 — — 13,600,000 
Balance at June 30, 2026100,000 $100 $61,424,900 $(17,556,403)$(3,976,489)$39,892,108 
Balance at December 31, 2024100,000 $100 $22,324,900 $(5,909,639)$(3,742,874)$12,672,487 
Net decrease in net assets resulting from operations— — — — (961,204)(961,204)
Return of capital to shareholder— — — (2,824,525)— (2,824,525)
Contributions from shareholder— — 10,000,000 — — 10,000,000 
Balance at June 30, 2025100,000 $100 $32,324,900 $(8,734,164)$(4,704,078)$18,886,758 
Balance at December 31, 2025100,000 $100 $40,824,900 $(10,454,770)$(3,976,489)$26,393,741 
Net increase in net assets resulting from operations
— — — — 3,555,493 3,555,493 
Distributions of income to shareholder— — — — (3,555,493)(3,555,493)
Return of capital to shareholder— — — (7,101,633)— (7,101,633)
Contributions from shareholder— — 20,600,000 — — 20,600,000 
Balance at June 30, 2026100,000 $100 $61,424,900 $(17,556,403)$(3,976,489)$39,892,108 









See notes to condensed financial statements (unaudited).
5



WTI FUND XI, INC.

CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)
FOR THE SIX MONTHS ENDED JUNE 30, 2026 AND 2025

For the Six Months Ended June 30, 2026
For the Six Months Ended June 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:
Net increase (decrease) in net assets resulting from operations$3,555,493 $(961,204)
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash used in operating activities:
Amortization of deferred costs related to debt facility339,287 333,516 
   Origination of loans(61,850,000)(18,304,000)
   Principal payments on loans, net of accretion17,203,808 795,138 
   Acquisition of equity securities(6,305,521)(2,199,654)
Changes in operating assets and liabilities:
Net increase in dividend and interest receivables(308,217)(292,527)
Net (increase) decrease in other assets(120,763)14,379 
Net increase (decrease) in accounts payable, other accrued liabilities and accrued management fees
194,597 (7,443)
Net cash used in operating activities(47,291,316)(20,621,795)
CASH FLOWS FROM FINANCING ACTIVITIES:
Cash distributions to shareholder(4,100,000) 
Contributions from shareholder20,600,000 10,000,000 
Borrowings under debt facility44,500,000 8,000,000 
Repayments of borrowings under debt facility(7,000,000)(3,000,000)
Payments of bank facility fees and costs(7,516)(1,695)
Net cash provided by financing activities53,992,484 14,998,305 
Net increase (decrease) in cash and cash equivalents6,701,168 (5,623,490)
CASH AND CASH EQUIVALENTS:
Beginning of period6,085,901 9,535,729 
End of period$12,787,069 $3,912,239 
SUPPLEMENTAL DISCLOSURES:
CASH PAID DURING THE PERIOD:   
Interest - Debt facility$1,876,083 $1,455,101 
NON-CASH OPERATING AND FINANCING ACTIVITIES:   
Distributions of equity securities to shareholder$6,557,126 $2,824,525 
Receipt of equity securities as repayment of loans$251,605 $624,871 


See notes to condensed financial statements (unaudited).
6


WTI FUND XI, INC.

CONDENSED SCHEDULE OF INVESTMENTS (UNAUDITED)
AS OF JUNE 30, 2026


IndustryBorrowerPercent of Net Assets (a)CollateralInterest Rate (b)End of Term Payment (c)PrincipalAmortized CostFair Value (d)Final Maturity Date
Biotechnology
Biolojic Design Ltd. ** ^Senior Secured12.5%$3,396,804 $3,170,173 $3,170,173 6/1/2029
Teiko Bio, Inc.Senior Secured12.5%250,000 243,076 243,076 10/1/2029
Teiko Bio, Inc.Senior Secured12.5%250,000 226,289 226,289 5/1/2029
Teiko Bio, Inc. Subtotal500,000 469,365 469,365 
Biotechnology Total9.1 %$3,896,804 $3,639,538 $3,639,538 
Computers & Storage
Proto, Inc.Senior Secured13.0%17.8%$213,720 $211,197 $211,197 7/1/2028
Computers & Storage Total
0.5 %$213,720 $211,197 $211,197 
Internet
Boss Bites Inc.Senior Secured12.0%$1,500,000 $1,431,785 $1,431,785 4/1/2029
Realm Living, Inc.Senior Secured12.5%286,441 249,630 249,630 3/1/2029
Slice Solutions, Inc.Senior Secured11.0%5,000,000 4,586,152 4,586,152 5/1/2031
Internet Total15.7 %$6,786,441 $6,267,567 $6,267,567 
Medical Devices
eXo Imaging, Inc.Senior Secured12.5%$1,250,000 $1,115,337 $1,115,337 12/1/2028
Gallant Pet, Inc.Senior Secured13.3%497,080 465,959 465,959 5/1/2028
Gallant Pet, Inc.Senior Secured13.0%298,053 298,053 298,053 5/1/2028
Gallant Pet, Inc. Subtotal795,133 764,012 764,012 
Medical Devices Total4.7 %$2,045,133 $1,879,349 $1,879,349 
Other Healthcare
Lark Technologies, Inc.Senior Secured13.5%$2,870,852 $2,432,734 $2,432,734 4/1/2028
MeMed Diagnostics Ltd. ** ^Senior Secured11.0%7.6%2,000,000 1,987,167 1,987,167 1/1/2030
MeMed Diagnostics Ltd. ** ^Senior Secured11.0%7.6%1,500,000 1,180,153 1,180,153 10/1/2029
MeMed Diagnostics Ltd. ** ^Senior Secured11.0%7.5%1,500,000 1,503,908 1,503,908 11/1/2029
MeMed Diagnostics Ltd. Subtotal ** ^5,000,000 4,671,228 4,671,228 
Vitable, Inc.Senior Secured13.0%1,000,000 984,325 984,325 4/1/2029
Vitable, Inc.Senior Secured13.0%1,500,000 1,435,533 1,435,533 4/1/2029
Vitable, Inc. Subtotal2,500,000 2,419,858 2,419,858 
Other Healthcare Total23.9 %$10,370,852 $9,523,820 $9,523,820 
Other Technology
AI Tech Holdings, Inc.Senior Secured12.0%$151,490 $141,076 $141,076 10/1/2028
Allocate Holdings Inc.Senior Secured10.5%5,500,000 5,234,910 5,234,910 7/1/2031
Belong, Inc.Senior Secured13.0%625,000 512,237 512,237 3/1/2029
Belong, Inc.Senior Secured13.5%250,000 224,515 224,515 3/1/2029
Belong, Inc.Senior Secured13.5%500,000 379,853 379,853 3/1/2029
Belong, Inc. Subtotal1,375,000 1,116,605 1,116,605 
Brick Dynamics Inc.Senior Secured12.0%500,000 465,747 465,747 4/1/2029
Brick Dynamics Inc.Senior Secured12.0%500,000 486,342 486,342 7/1/2029
Brick Dynamics Inc. Subtotal1,000,000 952,089 952,089 
Carbon Ridge, Inc.Senior Secured12.5%295,616 278,770 278,770 7/1/2028
7


IndustryBorrowerPercent of Net Assets (a)CollateralInterest Rate (b)End of Term Payment (c)PrincipalAmortized CostFair Value (d)Final Maturity Date
Carbon Ridge, Inc.Senior Secured12.5%355,796 343,424 343,424 1/1/2029
Carbon Ridge, Inc. Subtotal651,412 622,194 622,194 
Cofertility, Inc.Senior Secured11.8%750,000 637,793 637,793 8/1/2029
Creoate Limited ** ^Senior Secured12.8%123,682 122,880 122,880 6/1/2028
Creoate Limited ** ^Senior Secured12.8%44,069 43,770 43,770 8/1/2028
Creoate Limited ** ^Senior Secured12.8%125,000 122,205 122,205 8/1/2029
Creoate Limited ** ^Senior Secured12.8%250,000 244,681 244,681 7/1/2029
Creoate Limited ** ^Senior Secured12.8%141,358 140,274 140,274 10/1/2028
Creoate Limited ** ^Senior Secured12.8%128,196 127,327 127,327 7/1/2028
Creoate Limited ** ^Senior Secured12.8%145,632 144,439 144,439 11/1/2028
Creoate Limited ** ^Senior Secured12.8%161,560 160,224 160,224 12/1/2028
Creoate Limited ** ^Senior Secured12.8%109,305 79,756 79,756 4/1/2028
Creoate Limited ** ^Senior Secured12.8%375,000 352,701 352,701 5/1/2029
Creoate Limited ** ^Senior Secured12.8%158,397 157,361 157,361 5/1/2028
Creoate Limited Subtotal ** ^1,762,199 1,695,618 1,695,618 
Daisyco, Inc.Senior Secured10.8%1,250,000 1,170,894 1,170,894 4/1/2029
Fortull, Inc.Senior Secured11.0%125,000 120,793 120,793 4/1/2029
Fortull, Inc.Senior Secured11.0%125,000 109,020 109,020 1/1/2029
Fortull, Inc. Subtotal250,000 229,813 229,813 
Gold Words, LLCSenior Secured12.0%136,294 133,771 133,771 12/1/2027
Grin Technology Services Inc.Senior Secured12.0%1,000,000 887,804 887,804 10/1/2029
Hint, Inc.Senior Secured13.8%1,329,676 1,046,429 1,046,429 1/1/2028
Innventure LLC **Senior Secured13.5%4,130,427 2,380,150 2,380,150 6/1/2028
Joy Memories, IncSenior Secured12.8%1.5%4,000,000 3,259,455 3,259,455 1/1/2030
Kindred Motorworks, Inc.Senior Secured12.0%2,356,764 2,356,579 2,356,579 10/1/2028
Scripta Insights, Inc.Senior Secured12.5%572,440 552,472 552,472 4/1/2028
Umbra Lab, Inc.Senior Secured12.5%18,050,000 17,083,341 17,083,341 10/1/2029
Umbra Lab, Inc.Senior Secured13.5%1,680,653 1,639,269 1,639,269 1/1/2028
Umbra Lab, Inc. Subtotal19,730,653 18,722,610 18,722,610 
Other Technology Total103.1 %$45,946,355 $41,140,262 $41,140,262 
Semiconductors & Equipment
D2S, Inc.Senior Secured13.5%$2,500,000 $2,217,953 $2,217,953 5/1/2029
Semiconductors & Equipment Total5.6 %$2,500,000 $2,217,953 $2,217,953 
Software
APIsecAI, Inc.Senior Secured12.0%$433,981 $412,781 $412,781 5/1/2028
APIsecAI, Inc.Senior Secured12.0%250,000 243,621 243,621 1/1/2029
APIsecAI, Inc. Subtotal683,981 656,402 656,402 
Bito Inc.Senior Secured12.5%250,000 218,643 218,643 5/1/2029
Canvas Medical, Inc.Senior Secured12.0%1,750,000 1,637,471 1,637,471 10/1/2029
Checksum AI, Inc.Senior Secured11.3%1,000,000 944,747 944,747 10/1/2029
Crowded Technologies, Inc.Senior Secured12.5%187,500 160,457 160,457 12/1/2028
Crowded Technologies, Inc.Senior Secured12.5%187,500 182,365 182,365 1/1/2029
Crowded Technologies, Inc. Subtotal375,000 342,822 342,822 
Evolver Transformation, Inc.Senior Secured11.5%5,000,000 4,588,795 4,588,795 6/1/2031
Global Publishing Interactive, Inc.Senior Secured12.0%1,000,000 899,144 899,144 1/1/2030
Jericho Security, Inc.Senior Secured12.0%750,000 610,955 610,955 10/1/2029
Merlyn Mind, Inc.Senior Secured12.5%1,750,000 821,338 821,338 7/1/2030
Merlyn Mind, Inc.Senior Secured12.5%5,557,383 4,732,762 4,732,762 1/1/2029
8


IndustryBorrowerPercent of Net Assets (a)CollateralInterest Rate (b)End of Term Payment (c)PrincipalAmortized CostFair Value (d)Final Maturity Date
Merlyn Mind, Inc.Senior Secured12.5%750,000 354,200 354,200 6/1/2030
Merlyn Mind, Inc. Subtotal8,057,383 5,908,300 5,908,300 
Outbuild Technologies, Inc.Senior Secured12.0%1,675,000 1,598,882 1,598,882 3/1/2029
Safe Securities Inc.Senior Secured11.5%1.0%1,343,152 1,216,627 1,216,627 5/1/2029
Truepic Inc.Senior Secured12.3%396,622 389,034 389,034 5/1/2028
Truepic Inc.Senior Secured12.3%159,154 140,788 140,788 12/1/2027
Truepic Inc. Subtotal555,776 529,822 529,822 
Vesta Housing, Inc.Senior Secured15.0%1,974,052 2,014,052 2,014,052 *
Workspot, Inc.Senior Secured11.8%500,000 416,370 416,370 6/1/2029
ZeroCater, Inc.Senior Secured12.5%1,370,512 1,341,452 1,341,452 4/1/2028
Software Total57.5 %$26,284,856 $22,924,484 $22,924,484 
Technology Services
Ava Finance, Inc.Senior Secured10.8%1.5%$250,000 $247,067 $247,067 12/1/2028
Ava Finance, Inc.Senior Secured10.8%1.5%227,984 195,568 195,568 9/1/2028
Ava Finance, Inc.Senior Secured10.8%1.5%250,000 246,440 246,440 2/1/2029
Ava Finance, Inc.Senior Secured10.8%1.5%121,377 120,323 120,323 11/1/2028
Ava Finance, Inc.Senior Secured10.8%1.5%242,753 239,610 239,610 11/1/2028
Ava Finance, Inc.Senior Secured10.8%1.5%250,000 247,438 247,438 10/1/2028
Ava Finance, Inc.Senior Secured10.8%1.5%250,000 246,692 246,692 1/1/2029
Ava Finance, Inc. Subtotal1,592,114 1,543,138 1,543,138 
Klar Holdings Limited ** ^Senior Secured12.5%992,208 979,685 979,685 5/1/2028
Klar Holdings Limited ** ^Senior Secured12.5%915,186 852,683 852,683 3/1/2028
Klar Holdings Limited ** ^Senior Secured12.5%954,067 942,521 942,521 4/1/2028
Klar Holdings Limited Subtotal ** ^2,861,461 2,774,889 2,774,889 
Prima Holdings Limited ** ^Senior Secured13.0%2.0%670,854 653,099 653,099 1/1/2028
Technology Services Total12.5 %$5,124,429 $4,971,126 $4,971,126 
Wireless
Juvo Mobile, Inc. **Senior Secured12.5%$500,000 $455,180 $455,180 6/1/2028
Wireless Total1.1 %$500,000 $455,180 $455,180 
Grand Total 233.7 %$103,668,590 $93,230,476 $93,230,476 
* As of June 30, 2026, loans with a cost basis and fair value of $2.0 million were classified as non-accrual. These loans have been accelerated from their original maturity and are due in their entirety. During the period for which these loans have been on non-accrual status, no interest income has been recognized.
**Indicates assets that the Fund deems “non-qualifying assets.” As of June 30, 2026, 14.9% of the Fund’s total assets represented non-qualifying assets. Under Section 55(a) of the 1940 Act, the Fund is prohibited from acquiring any additional non-qualifying assets unless, at the time of acquisition, certain specified qualifying assets (e.g., securities issued by an “eligible portfolio company,” as defined in Section 2(a)(46)) represent at least 70% of its total assets. As part of this calculation, the numerator consists of the fair value of the Fund’s investments in all eligible portfolio companies, and the denominator consists of total assets less those assets described in Section 55(a)(7) of the 1940 Act.

^ Entity is not domiciled in the United States and does not have its principal place of business in the United States.
(a) The percentage of net assets that each industry group represents is shown with the industry totals (the sum of the percentages does not equal 100% because the percentages are based on net assets as opposed to total loans).

(b) The interest rate is the designated annual interest rate exclusive of any original issue discount, fees or end of term payment.

(c) The end of term payments are contractually due on the maturity date and are in addition to the interest rate shown. End of term payments are generally the percentage of the final payment divided by the original loan amount and are amortized over the full term of the loan.

(d) There is no readily available market price or secondary market for the Fund’s loan investments, hence the Manager determines fair value of all loan investments presented in the Condensed Schedule of Investments based on a most advantageous market and the estimates may include the use of significant unobservable inputs.

As of June 30, 2026, all loans were made to non-affiliates.

See notes to condensed financial statements (unaudited).

9


WTI FUND XI, INC.

CONDENSED SCHEDULE OF INVESTMENTS (UNAUDITED)
AS OF DECEMBER 31, 2025


IndustryBorrowerPercent of Net Assets (a)CollateralInterest Rate (b)End of Term Payment (c)PrincipalAmortized CostFair Value (d)Final Maturity Date
Biotechnology
Biolojic Design Ltd. ** ^Senior Secured12.5%3.0%$2,500,000 $2,367,516 $2,367,516 7/1/2028
Biolojic Design Ltd. ** ^Senior Secured12.5%3.0%1,250,000 1,227,535 1,227,535 7/1/2028
Biolojic Design Ltd. Subtotal ** ^3,750,000 3,595,051 3,595,051 
Biotechnology Total13.6%$3,750,000 $3,595,051 $3,595,051 
Computers & Storage
Proto, Inc.Senior Secured13.0%17.8%$250,000 $232,355 $232,355 7/1/2028
Computers & Storage Total0.9%$250,000 $232,355 $232,355 
Internet
Realm Living, Inc.Senior Secured12.5%$386,749 $372,203 $372,203 6/1/2027
Internet Total1.4%$386,749 $372,203 $372,203 
Medical Devices
eXo Imaging, Inc.Senior Secured12.5%$1,250,000 $1,073,170 $1,073,170 12/1/2028
Gallant Pet, Inc.Senior Secured13.3%607,263 560,846 560,846 5/1/2028
Gallant Pet, Inc.Senior Secured13.0%364,325 364,325 364,325 5/1/2028
Gallant Pet, Inc. Subtotal971,588 925,171 925,171 
Medical Devices Total7.6%$2,221,588 $1,998,341 $1,998,341 
Other Healthcare
Lark Technologies, Inc.Senior Secured13.5%$3,537,979 $2,884,323 $2,884,323 4/1/2028
Vitable, Inc.Senior Secured13.0%1,500,000 1,419,220 1,419,220 4/1/2029
Other Healthcare Total16.3%$5,037,979 $4,303,543 $4,303,543 
Other Technology
AI Tech Holdings, Inc.Senior Secured12.0%6.5%$178,784 $160,873 $160,873 10/1/2028
Belong, Inc.Senior Secured13.5%250,000 217,991 217,991 3/1/2029
Belong, Inc.Senior Secured13.5%500,000 352,208 352,208 3/1/2029
Belong, Inc. Subtotal750,000 570,199 570,199 
Carbon Ridge, Inc.Senior Secured12.5%375,000 358,472 358,472 1/1/2029
Carbon Ridge, Inc.Senior Secured12.5%355,807 331,373 331,373 7/1/2028
Carbon Ridge, Inc. Subtotal730,807 689,845 689,845 
Creoate Limited ** ^Senior Secured12.8%52,621 52,190 52,190 8/1/2028
Creoate Limited ** ^Senior Secured12.8%149,973 148,783 148,783 6/1/2028
Creoate Limited ** ^Senior Secured12.8%162,500 160,982 160,982 10/1/2028
Creoate Limited ** ^Senior Secured12.8%175,000 173,183 173,183 12/1/2028
Creoate Limited ** ^Senior Secured12.8%250,000 241,552 241,552 7/1/2029
Creoate Limited ** ^Senior Secured12.8%193,725 192,164 192,164 5/1/2028
Creoate Limited ** ^Senior Secured12.8%375,000 346,959 346,959 5/1/2029
Creoate Limited ** ^Senior Secured12.8%162,500 160,854 160,854 11/1/2028
Creoate Limited ** ^Senior Secured12.8%134,934 125,161 125,161 4/1/2028
Creoate Limited ** ^Senior Secured12.8%154,212 152,942 152,942 7/1/2028
Creoate Limited Subtotal ** ^1,810,465 1,754,770 1,754,770 
Daisyco, Inc.Senior Secured10.8%1,250,000 1,148,778 1,148,778 4/1/2029
Fortull, Inc.Senior Secured11.0%125,000 104,270 104,270 1/1/2029
Gold Words, LLCSenior Secured12.0%176,527 172,296 172,296 12/1/2027
Hint, Inc.Senior Secured13.8%1,654,066 1,212,785 1,212,785 1/1/2028
Innventure LLC **Senior Secured13.5%5,000,000 2,596,791 2,596,791 6/1/2028
Kindred Motorworks, Inc.Senior Secured12.0%6.4%2,500,000 2,444,410 2,444,410 7/1/2028
Last Energy Inc.Senior Secured13.8%1,415,456 1,315,947 1,315,947 4/1/2028
10


IndustryBorrowerPercent of Net Assets (a)CollateralInterest Rate (b)End of Term Payment (c)PrincipalAmortized CostFair Value (d)Final Maturity Date
Owlet Baby Care, Inc. **Senior Secured12.0%7.8%1,753,056 1,550,358 1,550,358 1/1/2028
Scripta Insights, Inc.Senior Secured12.5%707,063 676,534 676,534 4/1/2028
Umbra Lab, Inc.Senior Secured13.5%2,140,858 2,073,572 2,073,572 1/1/2028
Other Technology Total62.4%$20,192,082 $16,471,428 $16,471,428 
Software
APIsecAI, Inc.Senior Secured12.0%$250,000 $240,907 $240,907 1/1/2029
APIsecAI, Inc.Senior Secured12.0%500,000 468,391 468,391 5/1/2028
APIsecAI, Inc. Subtotal750,000 709,298 709,298 
Bito Inc.Senior Secured12.5%250,000 211,502 211,502 5/1/2029
Confirm HR, Inc.Senior Secured12.0%6.2%187,500 154,011 154,011 11/1/2028
Crowded Technologies, Inc.Senior Secured12.5%187,500 152,196 152,196 12/1/2028
Crowded Technologies, Inc.Senior Secured12.5%187,500 180,093 180,093 1/1/2029
Crowded Technologies, Inc. Subtotal375,000 332,289 332,289 
Manifold Inc.Senior Secured12.0%6.7%728,385 706,052 706,052 5/1/2028
Manifold Inc.Senior Secured12.0%6.5%250,000 235,775 235,775 7/1/2029
Manifold Inc. Subtotal978,385 941,827 941,827 
Merlyn Mind, Inc.Senior Secured12.5%5,498,201 4,464,422 4,464,422 1/1/2029
Safe Securities Inc.Senior Secured11.5%1.0%1,375,000 1,210,290 1,210,290 5/1/2029
Standard Dental OpCo, Inc.Senior Secured10.0%20.1%3,000,000 2,711,475 2,711,475 10/1/2026
Standard Dental OpCo, Inc.Senior Secured10.0%21.0%750,000 763,575 763,575 10/1/2026
Standard Dental OpCo, Inc. Subtotal3,750,000 3,475,050 3,475,050 
Truepic Inc.Senior Secured12.3%206,016 175,873 175,873 12/1/2027
Truepic Inc.Senior Secured12.3%485,634 474,197 474,197 5/1/2028
Truepic Inc. Subtotal691,650 650,070 650,070 
Vesta Housing, Inc.Senior Secured15.0%2.0%750,000 755,000 755,000 5/1/2026
Vesta Housing, Inc.Senior Secured15.0%2.0%500,000 504,516 504,516 4/1/2026
Vesta Housing, Inc.Senior Secured15.0%2.0%750,000 748,205 748,205 3/1/2026
Vesta Housing, Inc. Subtotal2,000,000 2,007,721 2,007,721 
ZeroCater, Inc.Senior Secured12.5%1,528,011 1,457,461 1,457,461 4/1/2028
Software Total59.1%$17,383,747 $15,613,941 $15,613,941 
Technology Services
Ava Finance, Inc.Senior Secured10.8%1.5%$250,000 $204,083 $204,083 9/1/2028
Ava Finance, Inc.Senior Secured10.8%1.5%250,000 244,559 244,559 11/1/2028
Ava Finance, Inc.Senior Secured10.8%1.5%250,000 244,921 244,921 2/1/2029
Ava Finance, Inc.Senior Secured10.8%1.5%250,000 245,154 245,154 1/1/2029
Ava Finance, Inc.Senior Secured10.8%1.5%250,000 245,539 245,539 12/1/2028
Ava Finance, Inc.Senior Secured10.8%1.5%250,000 245,835 245,835 10/1/2028
Ava Finance, Inc.Senior Secured10.8%1.5%125,000 122,980 122,980 11/1/2028
Ava Finance, Inc. Subtotal1,625,000 1,553,071 1,553,071 
Klar Holdings Limited ** ^Senior Secured12.5%1,141,884 1,045,078 1,045,078 3/1/2028
Klar Holdings Limited ** ^Senior Secured12.5%1,178,438 1,160,716 1,160,716 4/1/2028
Klar Holdings Limited ** ^Senior Secured12.5%1,214,197 1,195,316 1,195,316 5/1/2028
Klar Holdings Limited Subtotal ** ^3,534,519 3,401,110 3,401,110 
Prima Holdings Limited ** ^Senior Secured13.0%2.0%855,529 816,262 816,262 1/1/2028
Technology Services Total21.9%$6,015,048 $5,770,443 $5,770,443 
Wireless
Juvo Mobile, Inc. **Senior Secured12.5%$500,000 $478,584 $478,584 12/1/2027
Wireless Total1.8%$500,000 $478,584 $478,584 
Grand Total 185.0%$55,737,193 $48,835,889 $48,835,889 

11


**Indicates assets that the Fund deems “non-qualifying assets.” As of December 31, 2025, 25.8% of the Fund’s total assets represented non-qualifying assets. Under Section 55(a) of the 1940 Act, the Fund is prohibited from acquiring any additional non-qualifying assets unless, at the time of acquisition, certain specified qualifying assets (e.g., securities issued by an “eligible portfolio company,” as defined in Section 2(a)(46)) represent at least 70% of its total assets. As part of this calculation, the numerator consists of the fair value of the Fund’s investments in all eligible portfolio companies, and the denominator consists of total assets less those assets described in Section 55(a)(7) of the 1940 Act.

^ Entity is not domiciled in the United States and does not have its principal place of business in the United States.
(a) The percentage of net assets that each industry group represents is shown with the industry totals (the sum of the percentages does not equal 100% because the percentages are based on net assets as opposed to total loans).

(b) The interest rate is the designated annual interest rate exclusive of any original issue discount, fees or end of term payment.

(c) The end of term payments are contractually due on the maturity date and are in addition to the interest rate shown. End of term payments are generally the percentage of the final payment divided by the original loan amount and are amortized over the full term of the loan.

(d) There is no readily available market price or secondary market for the Fund’s loan investments, hence the Manager determines fair value of all loan investments presented in the Condensed Schedule of Investments based on a most advantageous market and the estimates may include the use of significant unobservable inputs.

As of December 31, 2025, all loans were made to non-affiliates.


See notes to condensed financial statements (unaudited).







12


WTI FUND XI, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)


1.ORGANIZATION AND OPERATIONS OF THE FUND

WTI Fund XI, Inc. (the “Fund”) was incorporated in Maryland on February 1, 2023, as a non-diversified, closed-end management investment company that elected to be treated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”) and is managed by Westech Investment Advisors LLC (the “Manager” or “Management”) whose ultimate parent is Ridgepost Capital, Inc. (formerly known as P10, Inc.), a Delaware corporation.

The Fund will be dissolved on December 31, 2033 unless the Board of Directors (the “Board”) opts to elect early dissolution. One hundred percent of the stock of the Fund is held by WTI Fund XI, LLC (the “Company”). Prior to commencing investment operations on June 26, 2024, the Fund issued 100,000 shares of common stock at $0.001 par value (the “Shares”) for $25,000 to the Company. This issuance of stock was a requirement to apply for a finance lender’s license from the California Department of Financial Protection and Innovation, which was obtained on February 13, 2024.

The Fund’s investment objective is to achieve superior risk-adjusted investment returns and it seeks to achieve that objective by providing debt financing to portfolio companies, most of which are private. The Fund generally receives warrants to acquire equity securities in connection with its portfolio investments and generally distributes these warrants to its shareholder upon receipt, or soon thereafter. The Fund also has guidelines for the percentages of total assets that are invested in different types of assets. The portfolio investments of the Fund primarily consist of debt financing to early and expansion stage venture capital-backed technology companies.


2. BASIS OF PRESENTATION

The accompanying condensed interim financial statements of the Fund have been prepared in accordance with United States Generally Accepted Accounting Principles (“U.S. GAAP”) for interim financial reporting and pursuant to the requirements for reporting on Form 10‑Q. Accordingly, they do not include all information and footnote disclosures required for audited annual financial statements. Certain disclosures have been omitted because they would substantially duplicate disclosures included in the Fund’s audited financial statements and related notes for the year ended December 31, 2025, which are included in the Fund’s Annual Report on Form 10‑K (“Form 10-K”) filed with the United States Securities and Exchange Commission (“SEC”) on March 13, 2026. These condensed interim financial statements should be read in conjunction with the audited financial statements and notes included in the Fund’s annual report on Form 10-K as of and for the year ended December 31, 2025, including Note 2 - Summary of Significant Accounting Policies, which discusses the Fund’s significant accounting policies and estimates. In the opinion of the Manager, the accompanying condensed interim financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the Fund’s financial position and results of operations for the interim periods presented. The results for the three and six months ended June 30, 2026 are not necessarily indicative of results for a full fiscal year.


3. FAIR VALUE DISCLOSURES

The Fund provides asset-based financing primarily to start-up and emerging growth venture-backed companies pursuant to commitments whereby the Fund agrees to finance assets and provide working or growth capital up to a specified amount for the term of the commitment, upon the terms and subject to the conditions specified by such commitment. Even though these loans are generally secured by the assets of the borrowers, the Fund in most cases is subject to the credit risk of such companies. As of June 30, 2026 and December 31, 2025, the Fund’s investments in loans were primarily to companies based within the United States and were diversified among borrowers in the industry segments shown in the Condensed Schedules of Investments. All loans are senior to unsecured creditors and other secured creditors, unless otherwise indicated in the Condensed Schedules of Investments.

The Fund defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; that is, a recovery price. The recovery price assumes the asset or liability was exchanged in an orderly transaction; it was not a forced liquidation or distressed sale. Because there is no readily available market price and no secondary market for substantially all of the loan investments made by the Fund to borrowing portfolio companies, Management determines fair value (or estimated recovery value) based on a transaction that would occur in the most advantageous market and several factors related to each borrower.

Loan balances in the Condensed Schedules of Investments are listed by borrower. Typically, a borrower’s balance will be composed of several loans drawn under a commitment made by the Fund with the interest rate on each loan fixed at the time each loan is funded. Each loan drawn under a commitment has a different maturity date and amount.



13


The following tables show the weighted-average interest rate of the performing loans and all loans:

For the Three Months EndedFor the Six Months Ended
Performing LoansJune 30, 2026June 30, 2025June 30, 2026
June 30, 2025
Weighted-Average Interest Rate – Cash15.72 %15.17 %19.44 %15.28 %
Weighted-Average Interest Rate – Non-Cash7.69 %8.00 %8.13 %7.86 %
Weighted-Average Interest Rate23.41 %23.17 %27.57 %23.14 %

For the Three Months EndedFor the Six Months Ended
All LoansJune 30, 2026June 30, 2025June 30, 2026
June 30, 2025
Weighted-Average Interest Rate – Cash15.62 %15.17 %19.36 %15.28 %
Weighted-Average Interest Rate – Non-Cash7.64 %8.00 %8.09 %7.86 %
Weighted-Average Interest Rate23.26 %23.17 %27.45 %23.14 %

Interest is calculated using the effective interest method, and rates earned by the Fund will fluctuate based on many factors including early payoffs, volatility of values ascribed to warrants and new loans funded during the period. Warrants and equity securities received in connection with loan transactions are measured at fair value at the time of acquisition; the non-cash portion of interest income represents the accretion of the discount of these warrants over the life of the loan.

The risk profile of a loan changes when events occur that impact the credit analysis of the borrower and loan as discussed in the Fund’s loan accounting policy. Such changes result in the fair value adjustments made to the individual loans, which in accordance with U.S. GAAP, would be based on the price that would be received to sell an asset or paid to settle a liability in an orderly transaction between market participants at the measurement date. Where the risk profile is consistent with the original underwriting, the cost basis of substantially all of the loans approximates fair value.

All loans as of June 30, 2026 and 2025 were pledged as collateral for the debt facility, and the Fund’s borrowings are generally collateralized by all assets of the Fund.

Valuation Hierarchy

Under the FASB ASC Topic 820 (“Fair Value Measurement”), the Fund categorizes its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Fund’s valuation techniques. A level is assigned to each fair value measurement based on the lowest level input that is significant to the fair value measurement in its entirety.

The three levels of the fair value hierarchy are defined as follows:
Level 1Unadjusted quoted prices for identical assets or liabilities in active markets that are accessible at the measurement date.
Level 2Prices or valuations based on observable inputs other than quoted prices in active markets for identical assets and liabilities.
Level 3Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

The Fund recognizes transfers between levels, if any, on the actual date of the event of change in circumstances that caused the transfer. There were no transfers in or out of Level 1, 2 or 3 during the three and six months ended June 30, 2026 and 2025.

For fair value disclosure purposes, the Fund has identified one class of financial instrument: loan investments. The Fund’s loan investments are individually negotiated and unique, and because there is little to no market in which these assets trade, the unobservable inputs for these assets are valued using estimated recovery values. As a result, the Fund’s loan investments are classified as Level 3.

The methodologies primarily employed by Management for valuation purposes consist of valuing loans based on the most advantageous market, as discussed in Note 2 - Summary of Significant Accounting Policies of the Fund’s audited financial statements included in the Form 10-K, and the “asset recovery” method. The asset recovery method is utilized once Management identifies a troubled loan. This methodology incorporates various alternative outcomes based on all available information as of the valuation date. Each outcome is assigned a weighting depending on the facts and circumstances which exist at the underlying portfolio company. In certain scenarios, Management identifies all relevant remaining assets and the expected value of the proceeds the Fund may receive for selling off tangible assets or intellectual property rights, redeploying those assets to other companies, recovering receivables, etc. In other circumstances, Management considers the portfolio company’s potential ability to raise an additional round of financing or to be acquired which then allows for full or partial recovery of the Fund’s loan.

The following tables provide quantitative information about the Fund’s Level 3 fair value measurements of the Fund’s investments by industry as of June 30, 2026 and December 31, 2025. In addition to the techniques and inputs noted in the tables below, the Fund may also use other valuation techniques and methodologies when determining its fair value measurements.

14


Investment Type - Level 3
Loan Investments
Fair Value at
June 30, 2026
Valuation Techniques / MethodologiesUnobservable InputRange
Weighted Average (a)
Biotechnology$3,639,538 Most advantageous market analysisMost advantageous market effective yield rate
16% - 18%
18%
Computers & Storage211,197 Most advantageous market analysisMost advantageous market effective yield rate
27% *
27%
Internet6,267,567 Most advantageous market analysisMost advantageous market effective yield rate
14% - 21%
15%
Medical Devices1,879,349 Most advantageous market analysisMost advantageous market effective yield rate
17% - 22%
20%
Other Healthcare9,523,820 Most advantageous market analysisMost advantageous market effective yield rate
15% - 17%
16%
Other Technology41,140,262 Most advantageous market analysisMost advantageous market effective yield rate
12% - 28%
16%
Semiconductors & Equipment2,217,953 Most advantageous market analysisMost advantageous market effective yield rate
21% *
21%
Software22,924,484 Most advantageous market analysisMost advantageous market effective yield rate
14% - 29%
20%
Asset recoveryProbability weighing of alternative outcomes
20% - 40% ^*
Technology Services4,971,126 Most advantageous market analysisMost advantageous market effective yield rate
14% - 19%
16%
Wireless455,180 Most advantageous market analysisMost advantageous market effective yield rate
23% *
23%
Total Loan Investments$93,230,476 
(a) The weighted-average most advantageous market effective yield rates were calculated using the relative fair value of the loans.
* There is only one loan within this industry that utilizes this valuation technique.
^ Probability weightings vary among loan investments within each industry based on different potential future outcomes.

Investment Type - Level 3
Loan Investments
Fair Value at
December 31, 2025
Valuation Techniques / MethodologiesUnobservable InputRange
Weighted Average (a)
Biotechnology$3,595,051 Most advantageous market analysisMost advantageous market effective yield rate
17% *
17%
Computers & Storage232,355 Most advantageous market analysisMost advantageous market effective yield rate
27% *
27%
Internet372,203 Most advantageous market analysisMost advantageous market effective yield rate
18%*
18%
Medical Devices1,998,341 Most advantageous market analysisMost advantageous market effective yield rate
17% -22%
20%
Other Healthcare4,303,543 Most advantageous market analysisMost advantageous market effective yield rate
16%*
16%
Other Technology16,471,428 Most advantageous market analysisMost advantageous market effective yield rate
14% - 29%
19%
Software15,613,941 Most advantageous market analysisMost advantageous market effective yield rate
16% - 27%
21%
Technology Services5,770,443 Most advantageous market analysisMost advantageous market effective yield rate
14% - 19%
16%
Wireless478,584 Most advantageous market analysisMost advantageous market effective yield rate
20%*
20%
Total Loan Investments$48,835,889 
(a) The weighted-average most advantageous market effective yield rates were calculated using the relative fair value of the loans.
* There is only one loan within this industry that utilizes this valuation technique.

Increases (or decreases) in the most advantageous market effective yield rate, in isolation, could result in a significantly lower (or higher) fair value measurement. Likewise, increases (or decreases) in the probability weighting of unfavorable outcomes could decrease (increase) the fair value of the loan investments significantly. These sensitivities vary across industry segments and individual borrowers.
15


The following tables present the balances of assets and liabilities as of June 30, 2026 and December 31, 2025 measured at fair value on a recurring basis:
As of June 30, 2026
ASSETS:Level 1Level 2Level 3Total
Loans
$ $ $93,230,476 $93,230,476 
Total$ $ $93,230,476 $93,230,476 
For a detailed listing of borrowers comprising this amount, please refer to the Condensed Schedules of Investments.
As of December 31, 2025
ASSETS:Level 1Level 2Level 3Total
Loans
$ $ $48,835,889 $48,835,889 
Total$ $ $48,835,889 $48,835,889 
For a detailed listing of borrowers comprising this amount, please refer to the Condensed Schedules of Investments.

The following tables provide a summary of changes in Level 3 assets measured at fair value on a recurring basis:

For the Three Months Ended
June 30, 2026
For the Six Months Ended
June 30, 2026
LoansWarrantsLoansWarrants
Beginning balance$66,761,212 $ $48,835,889 $ 
Acquisitions and originations34,500,000 4,241,976 61,850,000 6,557,126 
Principal payments on loans, net of accretion(8,030,736)— (17,455,413)— 
Distributions to shareholder— (4,241,976)— (6,557,126)
Ending balance$93,230,476 $ $93,230,476 $ 

For the Three Months
Ended June 30, 2025
For the Six Months Ended
June 30, 2025
LoansWarrantsLoansWarrants
Beginning balance$36,873,190 $ $23,982,777 $ 
Acquisitions and originations4,025,000 990,826 18,304,000 2,824,525 
Principal payments on loans, net of accretion(31,422)— (1,420,009)— 
Distributions to shareholder— (990,826)— (2,824,525)
Ending balance$40,866,768 $ $40,866,768 $ 

There were no changes in unrealized gains (losses) from the loans still held as of June 30, 2026 and 2025.


4.    EARNINGS (LOSS) PER SHARE

Basic earnings (loss) per share are computed by dividing net increase (decrease) in net assets resulting from operations by the weighted average common shares outstanding. Diluted earnings (loss) per share are computed by dividing net increase (decrease) in net assets resulting from operations by the weighted average common shares outstanding, including the dilutive effects of potential common shares (e.g., stock options). The Fund has no instruments that would be potential common shares; thus, reported basic and diluted earnings (loss) per share are the same.


5.    CAPITAL STOCK

As of both June 30, 2026 and December 31, 2025, there were 10,000,000 shares of $0.001 par value common stock authorized, and 100,000 shares issued and outstanding. Total committed capital of the Company as of both June 30, 2026 and December 31, 2025, was $389.4 million. Total contributed capital to the Company as of June 30, 2026 and December 31, 2025, was $77.9 million and $52.3 million, respectively, of which $61.4 million and $40.8 million were contributed to the Fund, respectively.
16


The chart below shows the distributions of the Fund for the six months ended June 30, 2026 and 2025.

For the Six Months Ended June 30, 2026 For the Six Months Ended June 30, 2025
Cash distributions$4,100,000 $ 
Distributions of securities6,557,126 2,824,525 
Total distributions to shareholder$10,657,126 $2,824,525 

Final classification of the distributions as either a return of capital or a distribution of income is an annual determination made at the
end of each year dependent upon the Fund’s current year cumulative earnings and profits.


6. DEBT FACILITY

The 1940 Act requires a BDC to meet certain levels of asset coverage with respect to its outstanding “senior securities,” which typically consist of outstanding borrowings under credit facilities and other debt instruments. BDCs are generally required to have an asset coverage of at least 200% but are permitted to increase the amount of indebtedness they may incur by lowering the asset coverage requirement from 200% to 150% if they make certain disclosures and obtain the approval by either (1) a “required majority,” as defined in Section 57(o) of the 1940 Act, of the BDC’s board of directors, including a majority of disinterested directors, with effectiveness one year after the date of such approval or (2) a majority of votes cast at a special or annual meeting of the BDC’s shareholders at which a quorum is present, which is effective the day after such shareholder approval.

On September 28, 2023, the Fund’s sole shareholder, the Company, approved a reduced asset coverage ratio of 150% for the Fund as permitted in Section 61(a)(2) of the 1940 Act. As of June 30, 2026 and December 31, 2025, the Fund’s asset coverage for borrowings was 160% and 192%, respectively.

On August 1, 2024, the Fund entered into a loan and security agreement with MUFG Bank Ltd. as the administrative agent and the lenders named therein that established a secured revolving credit facility in an initial amount of up to $250.0 million with the option to request that borrowing availability be increased up to $500.0 million, subject to further negotiation and credit approval.

Borrowings by the Fund are collateralized by (i) all portfolio investments and substantially all other assets held by the Fund and its subsidiaries, (ii) all equity interests of the Company in the Fund and all direct or indirect subsidiaries of the Fund, and (iii) the pledge of the uncalled capital commitments of all investors in the Company. Loans under the facility may be, at the option of the Fund, a Reference Rate Loan or a SOFR Loan, calculated at Term SOFR or Daily Compounded SOFR (each as defined below). The facility terminates on August 1, 2027, but can be accelerated in the event of default, such as the failure by the Fund to make timely interest or mandatory principal payments, if any.

The Fund pays interest on its borrowings. Borrowings under the facility, at the Fund’s discretion, will bear interest at an annual rate of either a (i) Reference Rate, plus an Applicable Reference Rate Margin (such loan, a “Reference Rate Loan”), (ii) Term SOFR plus the Applicable SOFR Margin (such loan, a “Term SOFR Loan”) or (iii) Daily Compounded SOFR plus the Applicable SOFR Margin (such loan, a “Daily Compounded SOFR Loan”). The interest period for each Term SOFR Loan shall at the option of the Fund be fixed at one, three or six months. Applicable SOFR Margin is the sum of (a) the product of (i) the Subscription Percentage calculated for such period and (ii) 2.50% and (b) the product of (i) the Portfolio Leverage Percentage for such period and (ii) 3.00%. As of June 30, 2026 and December 31, 2025, the Fund’s outstanding borrowings were entirely 1‑month Term SOFR Loans.

The Fund also pays a fee on the unused portion of the facility. When the Fund is using 50.00% or more of the maximum amount available under the loan agreement, the applicable commitment fee is 0.25% of the unused portion of the loan facility; otherwise, the applicable commitment fee is 0.50% of the unused portion. The Fund pays the unused credit line fee quarterly.

Bank fees and other costs of $2.0 million incurred in connection with the acquisition of the facility have been capitalized and are amortized to interest expense on a straight-line basis over the expected life of the facility, which is expected to terminate on August 1, 2027. As of June 30, 2026 and December 31, 2025, the remaining unamortized fees and costs amounted to $0.7 million and $1.1 million, respectively.

The facility is revolving and as such does not have a specified repayment schedule, although advances are secured by the assets of the Fund and thus repayments will be required as assets decline. The debt facility contains various covenants including financial covenants related to: (i) minimum debt service coverage ratio, (ii) interest coverage ratio, (iii) unfunded commitment ratio, (iv) maximum quarterly loan loss reserve ratio, (v) maximum annual loan loss reserve ratio and (vi) maximum loan loss test. There are also various restrictive covenants, including limitations on: (i) the incurrence of liens, (ii) consolidations, mergers and asset sales and (iii) capital expenditures. The Fund is also required to maintain derivative instruments covering a notional principal amount equal to at least 20% of the outstanding borrowings if subscription borrowing base is less than 25% of the Fund’s borrowing base. As of June 30, 2026 and December 31, 2025, Management is not aware of instances of non-compliance with financial covenants and the Fund is not yet required to comply with the minimum derivative requirement.

17


The carrying value of the Fund’s borrowings under the debt facility approximates fair value. The fair value of the borrowings leverages rates that are observable at commonly quoted intervals, which is classified as a Level 2 fair value measurement in the fair value hierarchy. As of June 30, 2026 and December 31, 2025, $66.0 million and $28.5 million, respectively, was outstanding under the debt facility, with a weighted average all-in interest rate of 6.2% and 6.3%, respectively.


7.    MANAGEMENT FEE AND RELATED PARTIES
Management Fee
As compensation for its services to the Fund, the Manager, from the date of the first capital contribution, June 25, 2024, receives an investment management fee from the Fund (the “Management Fee”). The aggregate annual amount of the Management Fee for each annual period (which is comprised of four whole fiscal quarters and which, in the case of the first year, commenced on the first day of the first fiscal quarter following the first capital contribution) calculated as a percentage of committed capital, is as follows:
Management Fee
Year 11.575%
Year 21.600%
Year 31.575%
Year 41.500%
Year 51.250%
Year 60.900%
Year 70.600%
Year 80.350%
Year 90.150%

There will be no Management Fee payable after the ninth-year anniversary of the first capital contribution date.

For the three and six months ended June 30, 2026 and 2025, Management Fees were calculated at 1.600% and 1.575% of the Company’s committed capital, respectively.

Management Fees of $1.6 million and $1.5 million were recognized as expenses for the three months ended June 30, 2026 and 2025, respectively. Management Fees of $3.1 million were recognized as expenses for both the six months ended June 30, 2026 and 2025, respectively.

Related Parties
Certain officers and directors of the Fund also serve as officers and directors of the Manager. The Articles of Incorporation of the Fund provide for indemnification of directors, officers, employees and agents (including the Manager) of the Fund to the fullest extent permitted by applicable state law and the 1940 Act, including the advance of expenses and reasonable counsel fees. The Articles of Incorporation of the Fund also contain a provision eliminating personal liability of a Fund director or officer to the Fund or its shareholder for monetary damages for certain breaches of their duty of care. For this reason, the Fund acquired a directors and officers insurance policy.
Transactions with WTI Fund X, Inc. (Fund X)

The Manager also serves as the investment manager for Fund X. So long as Fund X has capital available to invest in loan transactions with final maturities earlier than December 31, 2031 (the date on which Fund X’s existence automatically expires), the Fund may invest in each portfolio company in which Fund X invests, subject to the approval of the Fund’s Board. The Manager’s allocation process is designed to allocate investment opportunities fairly and equitably among the Fund and Fund X over time, and subject to the respective funds’ board approval, may be based on a methodology taking into account investment pace, the remaining commitment periods and other relevant factors.

The ability of the Fund to co-invest with Fund X and other clients advised by the Manager is subject to the conditions (the “Conditions”) with which the funds are currently complying while seeking certain exemptive relief from the SEC from the provisions of Sections 17(d) and 57 of the 1940 Act and Rule 17d-1 thereunder. To the extent that clients, other than Fund X, advised by the Manager (but in which the Manager has no proprietary interest) invest in opportunities available to the Fund, the Manager will allocate such opportunities among the Fund and such other clients in a manner deemed fair and equitable considering all of the circumstances in accordance with the Conditions.


18


8. COMMITMENTS AND CONTINGENCIES

Unexpired Unfunded Commitments

As of June 30, 2026 and December 31, 2025, the Fund’s unexpired unfunded commitments to borrowers totaled $36.0 million and $17.5 million, respectively. Because venture loans are privately negotiated transactions, investments in these assets are relatively illiquid. It is the Manager’s experience that not all unexpired unfunded commitments will be used by the borrowers. Many credit agreements contain provisions which are milestone dependent and not all borrowers will achieve these milestones. Additionally, the Fund’s credit agreements contain provisions that give relief from funding obligations in the event the borrower has a material adverse change to its financial condition. Therefore, the unexpired unfunded commitments do not necessarily reflect future cash requirements or future investments for the Fund.

The table below is the Fund’s unexpired unfunded commitments as of June 30, 2026:

BorrowerIndustry
Unexpired Unfunded Commitment
as of June 30, 2026
Expiration Date
Abacum Inc.Software$5,000,000 03/31/2027
Belong, Inc.Other Technology375,000 07/31/2026
Cofertility, Inc.Other Technology1,250,000 02/15/2027
Crowded Technologies, Inc.Software375,000 07/31/2026
eXo Imaging, Inc.Medical Devices1,250,000 07/31/2026
Fortull, Inc.Other Technology125,000 10/31/2026
Global Publishing Interactive, Inc.Software750,000 02/28/2027
Jericho Security, Inc.Software250,000 10/31/2026
Lucra Inc.Software3,000,000 07/31/2027
Merlyn Mind, Inc.Software5,000,000 12/31/2026
Orion Longevity, Inc.Other Technology3,500,000 09/30/2026
Outbuild Technologies, Inc.Software1,000,000 07/31/2026
Pioneers Educaton, Inc.Other Technology5,000,000 12/31/2026
Safe Securities Inc.Software3,625,000 06/30/2027
Slice Solutions, Inc.Internet2,500,000 12/15/2026
Workspot, Inc.Software1,500,000 06/30/2029
World View Enterprises Inc.Other Technology1,500,000 01/31/2027
Total$36,000,000 

The table below is the Fund’s unexpired unfunded commitments as of December 31, 2025:

BorrowerIndustry
Unexpired Unfunded Commitment
as of December 31, 2025
Expiration Date
Abacum Inc.Software$5,000,000 03/31/2027
Ava Finance, Inc.Technology Services500,000 03/31/2026
Bito Inc.Software125,000 03/31/2026
Creoate LimitedOther Technology125,000 01/31/2026
Crowded Technologies, Inc.Software375,000 07/31/2026
Daisyco, Inc.Other Technology1,250,000 06/30/2026
eXo Imaging, Inc.Medical Devices1,250,000 07/31/2026
Fortull, Inc.Other Technology250,000 10/31/2026
Lark Technologies, Inc.Other Healthcare2,500,000 04/30/2026
Prima Holdings LimitedTechnology Services1,000,000 04/30/2026
Safe Securities Inc.Software3,625,000 06/30/2027
Teiko Bio, Inc.Biotechnology500,000 06/30/2026
Vitable, Inc.Other Healthcare1,000,000 03/14/2026
Total$17,500,000 

Contingencies

In the normal course of business, the Manager may enter into certain contracts, on behalf of the Fund, that contain a variety of indemnifications. The Fund’s maximum exposure under these arrangements is unknown as this would involve future claims that may be made that have not yet occurred. Currently, no such claims exist or are expected to arise and, accordingly, the Fund has not accrued any liability in connection with such indemnifications.
19


9. SEGMENT INFORMATION

The Fund operates through a single operating and reportable segment with an objective to invest and generate returns by providing debt financing to start-up and emerging growth venture-backed companies across various geographies, primarily in the U.S.; revenues are derived from interest income earned on the debt financing. The Fund’s chief operating decision maker (“CODM”) is comprised of the officers of the Fund (inclusive of the Chief Executive Officer and Chief Financial Officer, among others) and evaluates segment performance and makes operating decisions of the Fund based on the net increase (or decrease) in net assets from operations (“net income”). In addition to numerous other factors and metrics, the CODM utilizes net income as a key metric in deciding whether to reinvest in the segment (i.e., loan fundings), call capital, pay dividends or service its debt. As the Fund’s operations comprise a single reportable segment, the segment assets are reflected on the accompanying Condensed Statements of Assets and Liabilities as “Total assets” and the significant segment expenses are listed on the accompanying Condensed Statements of Operations.


10. FINANCIAL HIGHLIGHTS

U.S. GAAP requires disclosure of financial highlights of the Fund for the three and six months ended June 30, 2026 and 2025.

The total rate of return is defined as the return based on the change in value during the period of a theoretical investment made at the beginning of the period. The total rate of return assumes a constant rate of return for the Fund during the period reported and weights each cash flow by the amount of time held in the Fund. This required methodology differs from an internal rate of return.

The ratios of expenses and net investment income (loss) to average net assets, calculated below, are annualized and are computed based upon the aggregate weighted average net assets of the Fund for the periods presented. Net investment income (loss) is inclusive of all investment income, net of expenses and excludes realized or unrealized gains and losses.

Beginning and ending net asset values per share are based on the beginning and ending number of shares outstanding. Other per share information is calculated based upon the aggregate weighted average net assets of the Fund for the periods presented.

The following per share data and ratios have been derived from the information provided in the financial statements:

For the Three Months Ended June 30, 2026For the Three Months Ended June 30, 2025For the Six Months Ended June 30, 2026 For the Six Months Ended June 30, 2025
Total return**
4.67%(1.31%)12.12%(5.66%)
Per share amounts:
Net asset value, beginning of period$309.65$201.42 $263.94$126.72 
Net investment income (loss)
16.69 (2.64)35.55 (9.61)
Net increase (decrease) in net assets resulting from operations
16.69 (2.64)35.55 (9.61)
Distributions of income to shareholder(16.69) (35.55) 
Return of capital to shareholder(46.73)(9.91)(71.02)(28.24)
Contributions from shareholder136.00  206.00 100.00 
Net asset value, end of period398.92 188.87 398.92 188.87 
Net assets, end of period$39,892,108 $18,886,758 $39,892,108 $18,886,758 
Ratios to average net assets:
Expenses*
31.24%51.17%34.48%54.97%
Net investment income (loss)*17.82%(5.25%)22.18%(10.37%)
Portfolio turn-over rate %%%%
     Average debt outstanding$53,875,000 $25,000,000 $44,428,571 $24,428,571 
*Annualized
**Total return amounts presented above are not annualized.

11. SUBSEQUENT EVENTS

Management evaluated subsequent events through the date of this Quarterly Report on Form 10-Q and determined that no subsequent events had occurred that would require accrual or disclosure in the financial statements.

20


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

In addition to the historical information contained herein, the information in this Quarterly Report on Form 10-Q contains certain “forward-looking statements” within the meaning of the securities laws. These forward-looking statements reflect the current view of the Fund with respect to future events and financial performance and are subject to several risks and uncertainties, many of which are beyond the Fund’s control. All statements, other than statements of historical facts included in this Quarterly Report, regarding the strategy, future operations, financial position, estimated revenues, projected costs, prospects, plans and objectives of the Fund are forward-looking statements. When used in this report, the words “will,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “project” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. All forward-looking statements speak only as of the date of this report. The Fund does not undertake any obligation to update or revise publicly any forward-looking statements, whether resulting from new information, future events or otherwise, except as required by law.

The reader of this Quarterly Report should understand that all such forward-looking statements are subject to various uncertainties and risks that could affect their outcome. The Fund’s actual results could differ materially from those suggested by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, variances in the actual versus projected growth in assets, return on assets, loan losses, expenses, rates charged on loans and earned on securities investments, competition and macro-economic changes including inflation, interest rate expectations, among other factors including those set forth in the section of this Quarterly Report titled “Risk Factors” and in Item 1A - “Risk Factors” in the Fund’s 2025 Annual Report on Form 10-K. This entire Quarterly Report should be read to put such forward-looking statements in context and to gain a more complete understanding of the uncertainties and risks involved in the Fund’s business.

Overview

The Fund is 100% owned by the Company. The Fund’s shares of common stock, at $0.001 par value, were sold to its sole shareholder, the Company, under a stock purchase agreement. The Fund has issued 100,000 of the Fund’s 10,000,000 authorized shares. The Company may make additional capital contributions to the Fund.
The Fund provides financing and advisory services to a variety of carefully selected venture-backed companies that have received equity funding from traditional sources of venture capital equity funding ( i.e. a professionally managed venture capital firm), as well as non-traditional sources of venture capital equity funding (e.g., angel investors, strategic investors, family offices, crowdfunding investment platforms, etc.) (collectively, “Venture-Backed Companies”), primarily throughout the United States, with a focus on growth-oriented companies. The Fund’s portfolio consists of companies in the communications, information services, media, technology (including software and technology-enabled business services), biotechnology, and medical devices industry sectors, among others. The Fund’s capital is generally used by its portfolio companies to finance acquisitions of fixed assets and working capital. The Fund’s Registration Statement on Form 10 became effective on April 1, 2024 and the Fund elected to be treated as a BDC on April 11, 2024. On June 25, 2024, the Company called and received its first capital and made its first capital contribution to the Fund on the following day. The Fund commenced its investment activities on June 26, 2024. While the Fund intends to operate as a non-diversified investment company within the meaning of Section 5(b)(2) of the 1940 Act, from time to time the Fund may act as a diversified investment company within the meaning of Section 5(b)(1) of the 1940 Act.
The Fund expects to be treated as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986 (the “Code”) for federal income tax purposes. Pursuant to this election, the Fund generally will not have to pay corporate-level taxes if a sufficient amount of income is distributed to its shareholder as dividends, allowing the Company to substantially reduce or eliminate its corporate-level tax liability.
The Fund will seek to meet the ongoing requirements, including the diversification requirements, to qualify as a RIC under the Code. If the Fund fails to meet these requirements, it will be taxed as an ordinary corporation on its taxable income for that year (even if that income is distributed to the members of the Company) and all distributions out of its earnings and profits will be taxable to the members of the Company as taxable income; thus, such income will be subject to a double layer of taxation. There is no assurance that the Fund will meet the ongoing requirements to qualify as a RIC for tax purposes.

The Fund’s investment objective is to achieve superior risk-adjusted investment returns and it seeks to achieve that objective by providing debt financing to portfolio companies, most of which are private debt securities. The Fund generally receives warrants to acquire equity securities in connection with its portfolio investments and generally distributes these warrants to its shareholder upon receipt, or soon thereafter. The Fund also has guidelines for the percentages of total assets that are invested in different types of assets.

The portfolio investments of the Fund primarily consist of debt financing to Venture-Backed Companies in the technology sector. The borrower’s ability to repay its loans may be adversely impacted by several factors, and as a result, the loan may not be fully repaid. Furthermore, the Fund’s security interest in any collateral over the borrower’s assets may be insufficient to make up any shortfall in payments. Some of the Fund’s portfolio companies may be impacted by rising inflation, which could have a material impact on their results of operations, specifically costs and revenues. As such, rising inflation may have an adverse impact on the portfolio borrowers’ ability to maintain their good credit standing, as well as their ability to pay their interest and principal obligations to the Fund. In addition, any projected future decreases in the Fund’s portfolio companies’ operating results due to inflation could adversely impact the fair value of those investments. Any decreases in the fair value of the Fund’s investments could result in future unrealized losses and therefore reduce the Fund’s net assets resulting from operations.

21


The Fund operates through a single operating and reportable segment for financial reporting purposes, consistent with how the officers of the Fund (inclusive of the Chief Executive Officer and Chief Financial Officer, among others), who are the Fund’s CODM, evaluate financial performance and allocate resources.

Transactions with Fund X

The Manager also serves as the investment manager for Fund X. So long as Fund X has capital available to invest in loan transactions with final maturities earlier than December 31, 2031 (the date on which Fund X’s existence automatically expires), the Fund may invest in each portfolio company in which Fund X invests, subject to the approval of the Fund’s Board. The Manager’s allocation process is designed to allocate investment opportunities fairly and equitably among the Fund and Fund X over time, and subject to board approval, may be based on a methodology taking into account investment pace, the remaining commitment periods and other relevant factors.

The ability of the Fund to co-invest with Fund X, and other clients advised by the Manager, is subject to the Conditions with which the funds are currently complying while seeking certain exemptive relief from the SEC from the provisions of Sections 17(d) and 57 of the 1940 Act and Rule 17d-1 thereunder. To the extent that clients, other than Fund X, advised by the Manager (but in which the Manager has no proprietary interest) invest in opportunities available to the Fund, the Manager will allocate such opportunities among the Fund and such other clients in a manner deemed fair and equitable considering all of the circumstances in accordance with the Conditions.

Critical Accounting Policies, Practices and Estimates

Critical Accounting Policies and Practices are those accounting policies and practices that are both the most important to the portrayal of the Fund’s net assets and results of operations and require the most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Critical accounting estimates are accounting estimates where the nature of the estimates is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change and the impact of the estimates on net assets or operating performance is material.

In evaluating the most critical accounting policies and estimates, the Manager has identified the estimation of fair value of the Fund’s loan investments along with the completeness of loans exhibiting indicators of potential credit deterioration as the most critical of the accounting policies and accounting estimates applied to the Fund’s reporting of net assets or operating performance. In accordance with U.S. GAAP, the Fund defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; that is, an exit price. The exit price assumes the asset or liability was exchanged in an orderly transaction; it was not a forced liquidation or distressed sale. There is no readily available market price or secondary market for the loans made by the Fund to borrowers, hence the Manager determines fair value based on a transaction that would occur in the most advantageous market and the estimates are subject to high levels of judgment and uncertainty. The Fund’s loan investments are considered Level 3 fair value measurements in the fair value hierarchy due to the lack of observability over many of the important inputs used in determining fair value. In particular, the Manager has identified the fair value of the Fund’s loan investments that exhibit indicators of the potential for credit deterioration and the completeness of those loan investments, as a critical accounting matter that may involve significant and material estimates and inputs from the Manager in determining the fair value of those loan investments.
Critical judgments and inputs in determining the fair value of a loan include the estimated timing and amount of future cash flows and probability of future payments, based on the assessment of payment history, available cash and “burn rate,” revenues, net income or loss, operating results, financial strength of borrower, prospects for the borrower’s raising future equity rounds, likelihood of sale or acquisition of the borrower, length of expected holding period of the loan, collateral position, the timing and amount of liquidation of collateral for loans that are experiencing significant credit deterioration and, as a result, collection becomes collateral-dependent, as well as an evaluation of the general interest rate environment. Management has evaluated these factors and has concluded that the effect of a deterioration in the quality of the underlying collateral, increase in the size of the loan, increase in the estimated time to recovery, and increase in the effective yield rate would each have the effect of decreasing the fair value of loan investments. The risk profile of a loan changes when events occur that impact the credit analysis of the borrower and the loan. Such changes result in the fair value being adjusted from par value of the individual loan. Where the risk profile is consistent with the original underwriting, the cost basis of substantially all loans approximates fair value.
The actual value of the loans may differ from Management’s estimates, which would affect net change in net assets resulting from operations as well as assets.

The Impact of Macro-level Conditions on Results of Operations and Liquidity & Capital Resources

Global and domestic financial markets remain volatile due to persistent inflationary pressures, interest rate fluctuations, and concerns about slowing economic growth. Geopolitical tensions, including the ongoing Ukraine War, war in the Middle East, in particular, involving the United States, Israel, Iran and the Gulf States, and continued instability in global shipping lanes have disrupted trade routes and supply chains. Recent escalations in the South China Sea and renewed cyberattacks targeting critical infrastructure have added to global uncertainty. Additionally, evolving U.S. government policies, global tariff regimes, and extreme weather events underscore the continuing political risk and risk of natural disasters and climate-related disruptions. These factors have created interruptions in supply chains and economic activity and have had a particularly adverse impact on certain industries. These uncertainties can ultimately impact the overall supply and demand of the market through changing spreads, deal terms and structures. The Fund is unable to predict the full impact of these macro risks on the Fund’s financial condition, including its liquidity and capital resources.

22


The Fund is continuing to maintain close communications with its loan portfolio companies, both those already funded and those in the pipeline, to proactively assess and manage potential risks. In addition, Management maintains oversight analysis of credits across the Fund’s loan investment portfolio in an attempt to manage the potential credit risk and improve loan performance. Certain loans may have inherent increased credit risk due to the nature of the underlying business and its ability to maintain operations in the current economic environment.

Management is also monitoring the Fund’s continued access to capital resources through periodic and timely communication with the bank syndicate and the Company’s members. In addition, the Fund will take proactive steps to ensure and maintain an appropriate liquidity position based on its circumstances. The Fund believes its existing cash balance, scheduled monthly payments from borrowers, and access to capital from its debt facility and the Company’s members will be sufficient to satisfy its working capital needs, debt repayments, and other liquidity requirements associated with its existing operations.

Results of Operations - For the Three and Six Months Ended June 30, 2026 and 2025
Analysis of Interest Income

Total investment income for the three months ended June 30, 2026 and 2025 was $4.6 million and $2.3 million, respectively. Investment income primarily consisted of interest on the venture loans outstanding and early loan payoffs. The remaining income consisted of dividends on the temporary investment of cash and other income from the forfeiture of commitment fees and deferred income from warrants.
Interest is calculated using the effective interest method, and rates earned by the Fund will fluctuate based on many factors including early payoffs, volatility of values ascribed to warrants and new loans funded during the year.
Warrants and equity securities received in connection with loan transactions are considered to be free standing contracts that are both legally detachable and separately exercisable from the related loan transactions and are measured at fair value at the time of acquisition; the non-cash portion of interest income represents the accretion of the discount of these warrants over the life of the loan.

The following table shows the average outstanding balance, interest income, and weighted average interest rate for the cash and non-cash portion of interest income for all loans for the three months ended June 30, 2026 and 2025.

For the Three Months Ended June 30, 2026
For the Three Months Ended June 30, 2025
Average Outstanding BalanceInterest IncomeWeighted Average Interest Rate - Cash PortionWeighted Average Interest Rate - Non-Cash PortionAverage Outstanding BalanceInterest IncomeWeighted Average Interest Rate - Cash PortionWeighted Average Interest Rate - Non-Cash Portion
Performing Loans$78,006,049 $4,566,628 15.72%7.69%$39,055,294 $2,261,659 15.17%8.00%
All Loans$78,509,562 $4,566,628 15.62%7.64%$39,055,294 $2,261,659 15.17%8.00%
Interest income for both performing loans and all loans increased by $2.3 million, or 101.9% for the three months ended June 30, 2026 compared to the same period in 2025. The increase is primarily due to the increase in the loan investment portfolio. The average outstanding balance for performing and all loans increased by $39.0 million and $39.5 million, or 99.7% and 101.0%, respectively for the three months ended June 30, 2026 compared to the same period in 2025.
The following table shows the average outstanding balance, interest income, and weighted average interest rate for the cash and non-cash portion of interest income for the six months ended June 30, 2026 and 2025.

For the Six Months Ended June 30, 2026 For the Six Months Ended June 30, 2025
Average Outstanding BalanceInterest IncomeWeighted Average Interest Rate - Cash PortionWeighted Average Interest Rate - Non-Cash PortionAverage Outstanding BalanceInterest IncomeWeighted Average Interest Rate - Cash PortionWeighted Average Interest Rate - Non-Cash Portion
Performing Loans$65,661,022 $9,050,895 19.44%8.13%$34,509,392 $3,992,697 15.28%7.86%
All Loans$65,948,744 $9,050,895 19.36%8.09%$34,509,392 $3,992,697 15.28%7.86%
Interest income for both performing and all loans increased by $5.1 million, or 126.7% for the six months ended June 30, 2026 compared to the same period in 2025. The increase is primarily due to the increase in the loan investment portfolio. The average outstanding balance for performing and all loans increased by $31.2 million and $31.4 million, or 90.3% and 91.1% for the six months ended June 30, 2026 compared to the same period in 2025.

23


Analysis of Interest Expense
Interest expense was comprised of amounts related to interest on debt amounts drawn down, unused credit line fees, and amounts amortized from deferred fees incurred in conjunction with the debt facility.

The following table shows the average balance, interest expense, and weighted average interest rate for the three months ended June 30, 2026 and 2025.
For the Three Months Ended June 30, 2026For the Three Months Ended June 30, 2025
Average BalanceInterest ExpenseWeighted Average Interest Expense RateAverage BalanceInterest ExpenseWeighted Average Interest Expense Rate
Debt Facility$53,875,000 $1,246,258 9.25 %$25,000,000 $883,477 14.14 %
Interest expense increased by $0.4 million, or 41.1%, for the three months ended June 30, 2026 compared to the same period in 2025. The increase is primarily due to the increase in the borrowings under the debt facility. The average outstanding balance for borrowings under the facility increased by $28.9 million, or 115.5%, for the three months ended June 30, 2026 compared to the same period in 2025.
The following table shows the average balance, interest expense, and weighted average interest expense rate for the six months ended June 30, 2026 and 2025.

For the Six Months Ended June 30, 2026 For the Six Months Ended June 30, 2025
Average BalanceInterest ExpenseWeighted Average Interest Expense RateAverage BalanceInterest ExpenseWeighted Average Interest Expense Rate
Debt Facility$44,428,571 $2,191,426 9.86 %$24,428,571 $1,744,274 14.28 %
Interest expense increased by $0.4 million, or 25.6%, for the six months ended June 30, 2026 compared to the same period in 2025. The increase is primarily due to the increase in the borrowings under the debt facility. The average outstanding balance for borrowings under the facility increased by $20.0 million, or 81.9%, for the six months ended June 30, 2026 compared to the same period in 2025.
Analysis of Operating Expenses

The following table shows the components of operating expenses for the three and six months ended June 30, 2026 and 2025.

For the Three Months Ended June 30,For the Six Months Ended June 30,
Operating Expense20262025Change ($)20262025Change ($)
Management Fees$1,553,530 $1,533,485 $20,045 $3,089,988 $3,081,428 $8,560 
Banking and professional fees 91,413 88,518 2,895 142,695 156,015 (13,320)
Other operating expenses33,446 69,493 (36,047)102,734 111,967 (9,233)
Total Operating Expenses$1,678,389 $1,691,496 $(13,107)$3,335,417 $3,349,410 $(13,993)
For the three and six months ended June 30, 2026 and 2025, Management Fees were calculated at 1.600% and 1.575% of the Company’s committed capital, respectively.
Banking and professional fees did not materially decrease for the three and six months ended June 30, 2026 compared to the same period in 2025. Banking and professional fees include legal fees related to client acquisition, audit and tax fees and consulting fees.
Other operating expenses did not materially decrease during the three and six months ended June 30, 2026 compared to the same period in 2025. Other expenses included director fees, custody fees, tax fees and other expenses related to the operations of the Fund.
Non-recurring fees

The Fund may receive non-recurring fees in connection with the origination and servicing of portfolio loans. Transactions in this category may include forfeited commitment fees and deferred income from warrants received that become recognized as other income after the loan commitment period expires. Other non-recurring fees include pre-payment fees which are recognized as other income in the period received. Legal fee reimbursements for deal due diligence and drafting of documents are recognized as offsets against legal expenses. Non-recurring fees were $0.2 million and $0.1 million for the three months ended June 30, 2026 and 2025, respectively. Non-recurring fees for the six months ended June 30, 2026 and 2025 were $0.4 million and $0.1 million, respectively.

Net Investment Income (Loss)

Net investment income (loss) for the three months ended June 30, 2026 and 2025 was $1.7 million and $(0.3) million, respectively. Net investment income (loss) for the six months ended June 30, 2026 and 2025 was $3.6 million and $(1.0) million, respectively.

24


Liquidity and Capital Resources – June 30, 2026 and December 31, 2025

The Fund is owned entirely by the Company. The Company is expected, but not required, to make further contributions to the capital of the Fund to the extent of the Company’s members’ capital commitment to the Company and excess cash balances of the Company. Total capital contributed to the Fund as of June 30, 2026 and December 31, 2025 was $61.4 million and $40.8 million, respectively. As of both June 30, 2026 and December 31, 2025, the Company had subscriptions for capital in the amount of $389.4 million, of which $77.9 million and $52.3 million, respectively, had been called and received. As of June 30, 2026, $311.5 million of capital remains uncalled.

The Fund expects to generate cash primarily from further contributions from the Company to the extent of the Company’s members’ capital commitment to the Company, cash flows from its operations and any financing arrangements it may enter into in the future.

The changes in cash for the six months ended June 30, 2026 and 2025 were as follows:
For the Six Months Ended June 30, 2026
For the Six Months Ended June 30, 2025
Net cash used in operating activities$(47,291,316)$(20,621,795)
Net cash provided by financing activities53,992,484 14,998,305 
Net increase (decrease) in cash and cash equivalents$6,701,168 $(5,623,490)

As of June 30, 2026 and December 31, 2025, 32.1% and 23.1%, respectively, of the Fund’s net assets consisted of cash.

On August 1, 2024, the Fund entered into a loan and security agreement with MUFG Bank Ltd. as the administrative agent and with lenders named therein that established a secured revolving credit facility in an initial amount of up to $250.0 million with the option to request that borrowing availability be increased up to $500.0 million, subject to further negotiation and credit approval.

Borrowings by the Fund are collateralized by (i) all portfolio investments and substantially all other assets held by the Fund and its subsidiaries, (ii) all equity interests of the Company in the Fund and all direct or indirect subsidiaries of the Fund, and (iii) the pledge of the uncalled capital commitments of all investors in the Company. The Fund pays interest on its borrowings and a fee on the unused portion of the facility. Borrowings under the facility, at the Fund’s discretion, will bear interest at an annual rate of either a (i) Reference Rate, plus an Applicable Reference Rate Margin (such loan, a “Reference Rate Loan”), (ii) Term SOFR plus the Applicable SOFR Margin (such loan, a “Term SOFR Loan”) or (iii) Daily Compounded SOFR plus the Applicable SOFR Margin (such loan, a “Daily Compounded SOFR Loan”). The interest period for each Term SOFR Loan shall at the option of the Fund be fixed at one, three or six months. Applicable SOFR Margin is the sum of (a) the product of (i) the Subscription Percentage calculated for such period and (ii) 2.50% and (b) the product of (i) the Portfolio Leverage Percentage for such period and (ii) 3.00%. When the Fund is using 50% or more of the maximum amount available under the loan agreement, the applicable commitment fee is 0.25% of the unused portion of the loan facility; otherwise, the applicable commitment fee is 0.50% of the unused portion. The Fund pays the unused credit line fee quarterly. The facility terminates on August 1, 2027, but can be accelerated in the event of default, such as the failure by the Fund to make timely interest or mandatory principal payments, if any. As of June 30, 2026, $66.0 million was outstanding under the facility.

Amounts disbursed under the Fund’s loan commitments were $61.9 million for the six months ended June 30, 2026. Net loan amounts outstanding after amortization increased by $44.4 million for the same period. Unexpired unfunded commitments totaled $36.0 million as of June 30, 2026.

As of Cumulative Amount Disbursed Principal Reductions and Fair Market AdjustmentsBalance Outstanding - Fair Value Unexpired Unfunded Commitments
June 30, 2026$121.7 million$28.4 million$93.2 million$36.0 million
December 31, 2025
$59.8 million$11.0 million$48.8 million$17.5 million

The unexpired unfunded commitments by portfolio company as of June 30, 2026 and December 31, 2025 are detailed in Note 8 to the financial statements included in this filing.

Because venture loans are privately negotiated transactions, investments in these assets are relatively illiquid. It is Management’s experience that not all unexpired unfunded commitments will be used by borrowers. Many credit agreements contain provisions that are milestone dependent and not all borrowers will achieve these milestones. Additionally, the Fund’s credit agreements contain provisions that give relief from funding obligations in the event the borrower has a materially adverse change in its financial condition. Therefore, the unexpired unfunded commitments do not necessarily reflect future cash requirements or future investments for the Fund.

25


The Fund will seek to maintain the requirements to qualify for the special pass-through status available to RICs under the Code, and thus to be relieved of federal income tax on that part of its net investment income and realized capital gains that it distributes to its shareholder. To qualify as a RIC, the Fund must distribute to its shareholder for each taxable year at least 90% of its investment company taxable income (consisting generally of net investment income and net short-term capital gain) (the “Distribution Requirement”). To the extent that the terms of the Fund’s venture loans provide for the receipt by the Fund of additional interest at the end of the loan term or provide for the receipt by the Fund of a purchase price for the asset at the end of the loan term (“residual income”), the Fund would be required to accrue such residual income over the life of the loan, and to include such accrued undistributed income in its gross income for each taxable year even if it receives no portion of such residual income in that year. Thus, in order to meet the Distribution Requirement and avoid payment of income taxes or an excise tax on undistributed income, the Fund may be required in a particular year to distribute as a dividend an amount in excess of the total amount of income it actually receives. Those distributions will be made from the Fund’s cash assets, from amounts received through amortization of loans or from borrowed funds.

As of June 30, 2026, the Fund had a cash balance of $12.8 million and $30.6 million in scheduled loan receivable payments over the next twelve months. Additionally, the Fund has access to uncalled capital of $311.5 million as a liquidity source and a borrowing base that grows as it funds additional commitments. These amounts are sufficient to meet the current commitment backlog and operational expenses of the Fund over the next year. The Fund regularly evaluates potential future liquidity resources and demands before making additional future commitments.

On September 28, 2023, the Fund’s sole shareholder, the Company, approved a reduced asset coverage ratio of 150% for the Fund as permitted in Section 61(a)(2) of the 1940 Act. Accordingly, the Fund is permitted to borrow in any amount so long as its asset coverage ratio, as defined in the 1940 Act, is at least 150% after giving effect to such borrowings. As of June 30, 2026, the Fund’s asset coverage ratio was 160%.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

The Fund’s business activities contain various elements of risk, of which Management considers interest rate and credit risk to be the principal types of risks. Because the Fund considers the management of risk essential to conducting its business and to maintaining profitability, the Fund’s risk management procedures are designed to identify and analyze the Fund’s risks, to set appropriate policies and limits and to continually monitor these risks and limits by means of reliable administrative and information systems and other policies and programs.

The Fund manages its market risk by maintaining a portfolio that is diverse by industry, size of investment, stage of development, and borrower. The Fund has limited exposure to public market price fluctuations as the Fund primarily invests in private business enterprises and distributes all equity investments upon receipt to the Company.

The Fund’s investments are subject to market risk based on several factors, including, but not limited to, the borrower’s credit history, available cash, support of the borrower’s underlying investors, available liquidity, “burn rate,” revenue income, security interest, secondary markets for collateral, the size of the loan, term of the loan and the ability to exit via initial public offering or merger and acquisition.

The Fund’s exposure to interest rate sensitivity is regularly monitored and analyzed by measuring the characteristics of assets and liabilities. The Fund utilizes various methods to assess interest rate risk in terms of the potential effect on interest income net of interest expense, the value of net assets and the value at risk in an effort to ensure that the Fund is insulated from any significant adverse effects from changes in interest rates. As of June 30, 2026, the outstanding debt balance was $66.0 million at a floating interest rate based on a Term SOFR rate of 3.6%.

Because all of the Fund’s loans impose a fixed interest rate upon funding, changes in short-term interest rates will not directly affect interest income associated with the loan portfolio as of June 30, 2026. However, those changes could have the potential to change the Fund’s ability to originate loan commitments, acquire and renew bank facilities, and engage in other investment activities. Further, changes in short-term interest rates could also affect interest expense and interest on the Fund’s short-term investments.

Based on the Fund’s Condensed Statements of Assets and Liabilities as of June 30, 2026, the following table shows the approximate annualized increase (decrease) in components of net assets resulting from operations of hypothetical base rate changes in interest rates, assuming no changes in investments or borrowings.
 
Effect of Interest Rate Change By
Increase (Decrease) in
Other Income
(Increase) Decrease in
Interest Expense
Increase (Decrease) in
Total Income
(2.00)%$(255,741)$1,320,000$1,064,259
(1.00)%$(127,871)$660,000$532,129
(0.50)%$(63,935)$330,000$266,065
0.50%$63,935$(330,000)$(266,065)
1.00%$127,871$(660,000)$(532,129)
2.00%$255,741$(1,320,000)$(1,064,259)
26


Although Management believes that the foregoing analysis is indicative of the Fund’s sensitivity to interest rate changes, it does not take into consideration potential changes in the credit market, credit quality, size and composition of the assets in the portfolio. It also does not assume any new fundings to borrowers, repayments from borrowers or defaults on borrowings. Accordingly, no assurances can be given that actual results would not differ materially from the table above.

Because the Fund currently borrows, its net investment income is highly dependent upon the difference between the rate at which it borrows and the rate at which it invests the amounts borrowed. Accordingly, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on the Fund’s investment activities and net investment income. The Fund’s exposure to movement in short-term interest rates stems from the Fund borrowing at a floating interest rate but then making loans with a fixed rate at the time the loans are extended.

The Fund is not sensitive to changes in foreign currency exchange rates, commodity prices and other market rates or prices.

Item 4.  Controls and Procedures

Disclosure Controls and Procedures:

At the end of the period covered by this report, the Fund carried out an evaluation under the supervision and with the participation of its Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Fund’s disclosure controls and procedures pursuant to Rules 13a-15(b) and 15d-15(b) of the Securities Exchange Act of 1934 (“Exchange Act”). Based upon this evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that the Fund’s disclosure controls and procedures were effective as of the end of the period in ensuring that information required to be disclosed was recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and in providing reasonable assurance that information required to be disclosed by the Fund in such reports is accumulated and communicated to the Fund’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures.

Changes in Internal Controls:
There have not been any changes in the Fund’s internal control over financial reporting identified in connection with the evaluation required by Rules 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the Fund’s fiscal quarter ended June 30, 2026 that have materially affected, or are reasonably likely to materially affect, the Fund’s internal control over financial reporting.
27


PART II — OTHER INFORMATION

Item 1.  Legal Proceedings

The Fund may become party to certain lawsuits from time to time in the normal course of business. While the outcome of any legal proceedings cannot now be predicted with certainty, the Fund does not expect any such proceedings will have a material effect upon the Fund’s financial condition or results of operations. Management is not aware of any pending legal proceedings involving the Fund. The Fund is not a party to any material legal proceedings.

Item 1A. Risk Factors

None.

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3.  Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5.  Other Information

Rule 10b5-1 Trading Arrangements

During the fiscal quarter ended June 30, 2026, no director or officer of the Fund adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement” (in each case, as defined in Item 408 of Regulation S-K).
28



Item 6.  Exhibits

Exhibit    
Exhibit Title
3.1
3.2
4.1
10.1
10.2
10.3
31.1
31.2
32.1
32.2


29


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
WTI FUND XI, INC.
(Registrant)
By:/s/David R. WanekBy:/s/Jared S. Thear
David R. WanekJared S. Thear
President and Chief Executive OfficerChief Financial Officer
(Principal Executive Officer)(Principal Financial Officer)
Date:  
August 13, 2026
Date:
August 13, 2026



30

ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

WTI XI 10-Q Q2 2026 EX-31.1

WTI XI 10-Q Q2 2026 EX-31.2

WTI XI 10-Q Q2 2026 EX-32.1

WTI XI 10-Q Q2 2026 EX-32.2

XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT

XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT

XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT

XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT

XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT

IDEA: R1.htm

IDEA: R2.htm

IDEA: R3.htm

IDEA: R4.htm

IDEA: R5.htm

IDEA: R6.htm

IDEA: R7.htm

IDEA: R8.htm

IDEA: R9.htm

IDEA: R10.htm

IDEA: R11.htm

IDEA: R12.htm

IDEA: R13.htm

IDEA: R14.htm

IDEA: R15.htm

IDEA: R16.htm

IDEA: R17.htm

IDEA: R18.htm

IDEA: R19.htm

IDEA: R20.htm

IDEA: R21.htm

IDEA: R22.htm

IDEA: R23.htm

IDEA: R24.htm

IDEA: R25.htm

IDEA: R26.htm

IDEA: R27.htm

IDEA: R28.htm

IDEA: R29.htm

IDEA: R30.htm

IDEA: R31.htm

IDEA: R32.htm

IDEA: R33.htm

IDEA: R34.htm

IDEA: R35.htm

IDEA: R36.htm

IDEA: R37.htm

IDEA: R38.htm

IDEA: R39.htm

IDEA: R40.htm

IDEA: R41.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: wti-20260630_htm.xml